Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for WT1_MTF1_ZBTB7B
Z-value: 1.06
Motif logo
Transcription factors associated with WT1_MTF1_ZBTB7B
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
WT1
|
ENSG00000184937.8 | WT1 transcription factor |
|
MTF1
|
ENSG00000188786.9 | metal regulatory transcription factor 1 |
|
ZBTB7B
|
ENSG00000160685.9 | zinc finger and BTB domain containing 7B |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| MTF1 | hg19_v2_chr1_-_38325256_38325292 | -0.50 | 5.3e-03 | Click! |
| WT1 | hg19_v2_chr11_-_32457075_32457095 | -0.05 | 7.8e-01 | Click! |
| ZBTB7B | hg19_v2_chr1_+_154975258_154975330 | 0.02 | 9.4e-01 | Click! |
Activity profile of WT1_MTF1_ZBTB7B motif
Sorted Z-values of WT1_MTF1_ZBTB7B motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr9_+_128509624 | 7.18 |
ENST00000342287.5
ENST00000373487.4 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
| chr9_+_128509663 | 6.28 |
ENST00000373489.5
ENST00000373483.2 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
| chr6_-_4135693 | 5.16 |
ENST00000495548.1
ENST00000380125.2 ENST00000465828.1 |
ECI2
|
enoyl-CoA delta isomerase 2 |
| chr6_-_4135825 | 5.04 |
ENST00000380118.3
ENST00000413766.2 ENST00000361538.2 |
ECI2
|
enoyl-CoA delta isomerase 2 |
| chr19_+_8429031 | 5.00 |
ENST00000301455.2
ENST00000541807.1 ENST00000393962.2 |
ANGPTL4
|
angiopoietin-like 4 |
| chr9_+_137218362 | 4.92 |
ENST00000481739.1
|
RXRA
|
retinoid X receptor, alpha |
| chr1_-_20812690 | 4.58 |
ENST00000375078.3
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
| chr19_-_19051927 | 4.24 |
ENST00000600077.1
|
HOMER3
|
homer homolog 3 (Drosophila) |
| chr5_-_127873659 | 4.06 |
ENST00000262464.4
|
FBN2
|
fibrillin 2 |
| chr8_+_86376081 | 3.98 |
ENST00000285379.5
|
CA2
|
carbonic anhydrase II |
| chr1_+_150522222 | 3.73 |
ENST00000369039.5
|
ADAMTSL4
|
ADAMTS-like 4 |
| chr18_-_21242833 | 3.61 |
ENST00000586087.1
ENST00000592179.1 |
ANKRD29
|
ankyrin repeat domain 29 |
| chr9_-_123639304 | 3.57 |
ENST00000436309.1
|
PHF19
|
PHD finger protein 19 |
| chr2_-_72375167 | 3.55 |
ENST00000001146.2
|
CYP26B1
|
cytochrome P450, family 26, subfamily B, polypeptide 1 |
| chr3_-_124774802 | 3.50 |
ENST00000311127.4
|
HEG1
|
heart development protein with EGF-like domains 1 |
| chr7_+_157318477 | 3.38 |
ENST00000444154.1
|
AC006372.1
|
AC006372.1 |
| chr19_+_917287 | 3.34 |
ENST00000592648.1
ENST00000234371.5 |
KISS1R
|
KISS1 receptor |
| chr11_-_568369 | 3.31 |
ENST00000534540.1
ENST00000528245.1 ENST00000500447.1 ENST00000533920.1 |
MIR210HG
|
MIR210 host gene (non-protein coding) |
| chr2_-_235405679 | 3.30 |
ENST00000390645.2
|
ARL4C
|
ADP-ribosylation factor-like 4C |
| chr1_-_9189229 | 3.25 |
ENST00000377411.4
|
GPR157
|
G protein-coupled receptor 157 |
| chr18_-_21242774 | 3.18 |
ENST00000322980.9
|
ANKRD29
|
ankyrin repeat domain 29 |
| chr10_-_43762329 | 3.17 |
ENST00000395810.1
|
RASGEF1A
|
RasGEF domain family, member 1A |
| chr3_-_13921594 | 3.09 |
ENST00000285018.4
|
WNT7A
|
wingless-type MMTV integration site family, member 7A |
| chr2_+_238536207 | 3.08 |
ENST00000308482.9
|
LRRFIP1
|
leucine rich repeat (in FLII) interacting protein 1 |
| chr19_-_19051993 | 3.08 |
ENST00000594794.1
ENST00000355887.6 ENST00000392351.3 ENST00000596482.1 |
HOMER3
|
homer homolog 3 (Drosophila) |
| chr1_-_22263790 | 3.01 |
ENST00000374695.3
|
HSPG2
|
heparan sulfate proteoglycan 2 |
| chrX_+_135229731 | 2.98 |
ENST00000420362.1
|
FHL1
|
four and a half LIM domains 1 |
| chrX_+_135229600 | 2.95 |
ENST00000370690.3
|
FHL1
|
four and a half LIM domains 1 |
| chr21_+_35445827 | 2.94 |
ENST00000608209.1
ENST00000381151.3 |
SLC5A3
SLC5A3
|
sodium/myo-inositol cotransporter solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 |
| chr11_-_2906979 | 2.94 |
ENST00000380725.1
ENST00000313407.6 ENST00000430149.2 ENST00000440480.2 ENST00000414822.3 |
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
| chrX_-_152939133 | 2.94 |
ENST00000370150.1
|
PNCK
|
pregnancy up-regulated nonubiquitous CaM kinase |
| chr10_-_75634219 | 2.91 |
ENST00000305762.7
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma |
| chr18_+_33877654 | 2.88 |
ENST00000257209.4
ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3
|
formin homology 2 domain containing 3 |
| chr19_-_49015050 | 2.85 |
ENST00000600059.1
|
LMTK3
|
lemur tyrosine kinase 3 |
| chr11_+_69924639 | 2.84 |
ENST00000538023.1
ENST00000398543.2 |
ANO1
|
anoctamin 1, calcium activated chloride channel |
| chr7_-_98741642 | 2.83 |
ENST00000361368.2
|
SMURF1
|
SMAD specific E3 ubiquitin protein ligase 1 |
| chr21_-_44846999 | 2.83 |
ENST00000270162.6
|
SIK1
|
salt-inducible kinase 1 |
| chr10_+_11784360 | 2.82 |
ENST00000379215.4
ENST00000420401.1 |
ECHDC3
|
enoyl CoA hydratase domain containing 3 |
| chr22_-_43583079 | 2.80 |
ENST00000216129.6
|
TTLL12
|
tubulin tyrosine ligase-like family, member 12 |
| chr2_-_235405168 | 2.78 |
ENST00000339728.3
|
ARL4C
|
ADP-ribosylation factor-like 4C |
| chr1_+_65886244 | 2.78 |
ENST00000344610.8
|
LEPR
|
leptin receptor |
| chr8_-_10588010 | 2.77 |
ENST00000304501.1
|
SOX7
|
SRY (sex determining region Y)-box 7 |
| chr8_-_125740514 | 2.77 |
ENST00000325064.5
ENST00000518547.1 |
MTSS1
|
metastasis suppressor 1 |
| chr16_+_58497567 | 2.73 |
ENST00000258187.5
|
NDRG4
|
NDRG family member 4 |
| chrX_-_152939252 | 2.72 |
ENST00000340888.3
|
PNCK
|
pregnancy up-regulated nonubiquitous CaM kinase |
| chr6_+_37137939 | 2.70 |
ENST00000373509.5
|
PIM1
|
pim-1 oncogene |
| chr2_-_208031542 | 2.70 |
ENST00000423015.1
|
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
| chr19_+_35645817 | 2.70 |
ENST00000423817.3
|
FXYD5
|
FXYD domain containing ion transport regulator 5 |
| chr12_-_122238464 | 2.70 |
ENST00000546227.1
|
RHOF
|
ras homolog family member F (in filopodia) |
| chr10_-_79397391 | 2.69 |
ENST00000286628.8
ENST00000406533.3 ENST00000354353.5 ENST00000404857.1 |
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
| chr14_+_94640633 | 2.68 |
ENST00000304338.3
|
PPP4R4
|
protein phosphatase 4, regulatory subunit 4 |
| chr22_-_37823468 | 2.67 |
ENST00000402918.2
|
ELFN2
|
extracellular leucine-rich repeat and fibronectin type III domain containing 2 |
| chrX_+_135229559 | 2.65 |
ENST00000394155.2
|
FHL1
|
four and a half LIM domains 1 |
| chr11_-_2160611 | 2.62 |
ENST00000416167.2
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr17_-_76921459 | 2.62 |
ENST00000262768.7
|
TIMP2
|
TIMP metallopeptidase inhibitor 2 |
| chr16_+_66638616 | 2.59 |
ENST00000564060.1
ENST00000565922.1 |
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
| chr21_+_35445811 | 2.59 |
ENST00000399312.2
|
MRPS6
|
mitochondrial ribosomal protein S6 |
| chr15_+_80696666 | 2.57 |
ENST00000303329.4
|
ARNT2
|
aryl-hydrocarbon receptor nuclear translocator 2 |
| chr10_-_75634260 | 2.56 |
ENST00000372765.1
ENST00000351293.3 |
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma |
| chr17_-_58469591 | 2.56 |
ENST00000589335.1
|
USP32
|
ubiquitin specific peptidase 32 |
| chr20_+_306177 | 2.52 |
ENST00000544632.1
|
SOX12
|
SRY (sex determining region Y)-box 12 |
| chr1_-_6545502 | 2.49 |
ENST00000535355.1
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
| chr16_+_66638685 | 2.48 |
ENST00000565003.1
|
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
| chr1_-_205419053 | 2.46 |
ENST00000367154.1
|
LEMD1
|
LEM domain containing 1 |
| chr8_-_144651024 | 2.46 |
ENST00000524906.1
ENST00000532862.1 ENST00000534459.1 |
MROH6
|
maestro heat-like repeat family member 6 |
| chr2_+_95691445 | 2.44 |
ENST00000353004.3
ENST00000354078.3 ENST00000349807.3 |
MAL
|
mal, T-cell differentiation protein |
| chr1_-_93426998 | 2.44 |
ENST00000370310.4
|
FAM69A
|
family with sequence similarity 69, member A |
| chr12_-_28123206 | 2.43 |
ENST00000542963.1
ENST00000535992.1 |
PTHLH
|
parathyroid hormone-like hormone |
| chr8_+_22022800 | 2.42 |
ENST00000397814.3
|
BMP1
|
bone morphogenetic protein 1 |
| chr6_-_30654977 | 2.41 |
ENST00000399199.3
|
PPP1R18
|
protein phosphatase 1, regulatory subunit 18 |
| chr11_-_2160180 | 2.40 |
ENST00000381406.4
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr19_+_54926621 | 2.39 |
ENST00000376530.3
ENST00000445095.1 ENST00000391739.3 ENST00000376531.3 |
TTYH1
|
tweety family member 1 |
| chr20_+_57466629 | 2.39 |
ENST00000371081.1
ENST00000338783.6 |
GNAS
|
GNAS complex locus |
| chr14_+_94640671 | 2.36 |
ENST00000328839.3
|
PPP4R4
|
protein phosphatase 4, regulatory subunit 4 |
| chr9_+_125137565 | 2.36 |
ENST00000373698.5
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
| chr2_-_241396131 | 2.36 |
ENST00000404327.3
|
AC110619.2
|
Uncharacterized protein |
| chr16_+_66638567 | 2.33 |
ENST00000567572.1
|
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
| chr2_+_9346892 | 2.31 |
ENST00000281419.3
ENST00000315273.4 |
ASAP2
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
| chr2_-_165477971 | 2.31 |
ENST00000446413.2
|
GRB14
|
growth factor receptor-bound protein 14 |
| chr1_+_65886326 | 2.30 |
ENST00000371059.3
ENST00000371060.3 ENST00000349533.6 ENST00000406510.3 |
LEPR
|
leptin receptor |
| chr2_+_30454390 | 2.28 |
ENST00000395323.3
ENST00000406087.1 ENST00000404397.1 |
LBH
|
limb bud and heart development |
| chr11_+_849816 | 2.28 |
ENST00000527644.1
|
TSPAN4
|
tetraspanin 4 |
| chr7_+_73703728 | 2.28 |
ENST00000361545.5
ENST00000223398.6 |
CLIP2
|
CAP-GLY domain containing linker protein 2 |
| chr4_+_1873100 | 2.27 |
ENST00000508803.1
|
WHSC1
|
Wolf-Hirschhorn syndrome candidate 1 |
| chr7_-_50861129 | 2.27 |
ENST00000439044.1
ENST00000402497.1 ENST00000335866.3 |
GRB10
|
growth factor receptor-bound protein 10 |
| chr9_-_123639445 | 2.24 |
ENST00000312189.6
|
PHF19
|
PHD finger protein 19 |
| chr10_-_15210666 | 2.22 |
ENST00000378165.4
|
NMT2
|
N-myristoyltransferase 2 |
| chr15_+_57884117 | 2.22 |
ENST00000267853.5
|
MYZAP
|
myocardial zonula adherens protein |
| chr9_+_139560197 | 2.21 |
ENST00000371698.3
|
EGFL7
|
EGF-like-domain, multiple 7 |
| chr19_+_54926601 | 2.21 |
ENST00000301194.4
|
TTYH1
|
tweety family member 1 |
| chr12_-_28122980 | 2.21 |
ENST00000395868.3
ENST00000534890.1 |
PTHLH
|
parathyroid hormone-like hormone |
| chr19_+_2096868 | 2.20 |
ENST00000395296.1
ENST00000395301.3 |
IZUMO4
|
IZUMO family member 4 |
| chrX_-_153599578 | 2.20 |
ENST00000360319.4
ENST00000344736.4 |
FLNA
|
filamin A, alpha |
| chr3_-_52567792 | 2.19 |
ENST00000307092.4
ENST00000422318.2 ENST00000459839.1 |
NT5DC2
|
5'-nucleotidase domain containing 2 |
| chr2_-_1748214 | 2.19 |
ENST00000433670.1
ENST00000425171.1 ENST00000252804.4 |
PXDN
|
peroxidasin homolog (Drosophila) |
| chr2_-_25896380 | 2.18 |
ENST00000545439.1
ENST00000407186.1 ENST00000406818.3 ENST00000404103.3 ENST00000407661.3 ENST00000407038.3 ENST00000405222.1 ENST00000288642.8 |
DTNB
|
dystrobrevin, beta |
| chr10_-_75634326 | 2.17 |
ENST00000322635.3
ENST00000444854.2 ENST00000423381.1 ENST00000322680.3 ENST00000394762.2 |
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma |
| chr7_+_40174565 | 2.17 |
ENST00000309930.5
ENST00000401647.2 ENST00000335693.4 ENST00000413931.1 ENST00000416370.1 ENST00000540834.1 |
C7orf10
|
succinylCoA:glutarate-CoA transferase |
| chr14_+_105190514 | 2.17 |
ENST00000330877.2
|
ADSSL1
|
adenylosuccinate synthase like 1 |
| chr2_-_9143786 | 2.16 |
ENST00000462696.1
ENST00000305997.3 |
MBOAT2
|
membrane bound O-acyltransferase domain containing 2 |
| chr7_-_28220354 | 2.16 |
ENST00000283928.5
|
JAZF1
|
JAZF zinc finger 1 |
| chr14_-_75079026 | 2.14 |
ENST00000261978.4
|
LTBP2
|
latent transforming growth factor beta binding protein 2 |
| chr20_-_56284816 | 2.14 |
ENST00000395819.3
ENST00000341744.3 |
PMEPA1
|
prostate transmembrane protein, androgen induced 1 |
| chr11_-_12030629 | 2.13 |
ENST00000396505.2
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
| chr17_+_79989500 | 2.13 |
ENST00000306897.4
|
RAC3
|
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
| chr8_+_31497271 | 2.13 |
ENST00000520407.1
|
NRG1
|
neuregulin 1 |
| chr20_+_6748311 | 2.12 |
ENST00000378827.4
|
BMP2
|
bone morphogenetic protein 2 |
| chr19_-_1568057 | 2.11 |
ENST00000402693.4
ENST00000388824.6 |
MEX3D
|
mex-3 RNA binding family member D |
| chr3_+_12329397 | 2.11 |
ENST00000397015.2
|
PPARG
|
peroxisome proliferator-activated receptor gamma |
| chr14_+_105886150 | 2.11 |
ENST00000331320.7
ENST00000406191.1 |
MTA1
|
metastasis associated 1 |
| chr14_+_100070869 | 2.10 |
ENST00000502101.2
|
RP11-543C4.1
|
RP11-543C4.1 |
| chr2_+_95691417 | 2.10 |
ENST00000309988.4
|
MAL
|
mal, T-cell differentiation protein |
| chr22_-_37915535 | 2.09 |
ENST00000403299.1
|
CARD10
|
caspase recruitment domain family, member 10 |
| chr11_+_64001962 | 2.08 |
ENST00000309422.2
|
VEGFB
|
vascular endothelial growth factor B |
| chr11_-_66725837 | 2.08 |
ENST00000393958.2
ENST00000393960.1 ENST00000524491.1 ENST00000355677.3 |
PC
|
pyruvate carboxylase |
| chr18_+_56338750 | 2.08 |
ENST00000345724.3
|
MALT1
|
mucosa associated lymphoid tissue lymphoma translocation gene 1 |
| chr20_+_34204939 | 2.07 |
ENST00000454819.1
|
SPAG4
|
sperm associated antigen 4 |
| chr13_-_20806440 | 2.06 |
ENST00000400066.3
ENST00000400065.3 ENST00000356192.6 |
GJB6
|
gap junction protein, beta 6, 30kDa |
| chr1_-_244013384 | 2.06 |
ENST00000366539.1
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3 |
| chr4_-_57522470 | 2.06 |
ENST00000503639.3
|
HOPX
|
HOP homeobox |
| chr1_+_15736359 | 2.05 |
ENST00000375980.4
|
EFHD2
|
EF-hand domain family, member D2 |
| chr2_-_110371664 | 2.02 |
ENST00000545389.1
ENST00000423520.1 |
SEPT10
|
septin 10 |
| chr7_+_139478030 | 2.02 |
ENST00000425687.1
ENST00000263552.6 ENST00000438104.1 ENST00000336425.5 |
TBXAS1
|
thromboxane A synthase 1 (platelet) |
| chr12_+_96588279 | 2.02 |
ENST00000552142.1
|
ELK3
|
ELK3, ETS-domain protein (SRF accessory protein 2) |
| chr9_-_123639600 | 2.02 |
ENST00000373896.3
|
PHF19
|
PHD finger protein 19 |
| chr1_-_6321035 | 2.01 |
ENST00000377893.2
|
GPR153
|
G protein-coupled receptor 153 |
| chr19_-_14629224 | 2.00 |
ENST00000254322.2
|
DNAJB1
|
DnaJ (Hsp40) homolog, subfamily B, member 1 |
| chr15_+_57884086 | 1.99 |
ENST00000380569.2
ENST00000380561.2 ENST00000574161.1 ENST00000572390.1 ENST00000396180.1 ENST00000380560.2 |
GCOM1
|
GRINL1A complex locus 1 |
| chr7_+_48128854 | 1.99 |
ENST00000436673.1
ENST00000429491.2 |
UPP1
|
uridine phosphorylase 1 |
| chr16_-_84651647 | 1.98 |
ENST00000564057.1
|
COTL1
|
coactosin-like 1 (Dictyostelium) |
| chr2_+_220306745 | 1.97 |
ENST00000431523.1
ENST00000396698.1 ENST00000396695.2 |
SPEG
|
SPEG complex locus |
| chr16_-_84651673 | 1.97 |
ENST00000262428.4
|
COTL1
|
coactosin-like 1 (Dictyostelium) |
| chr11_+_126225789 | 1.95 |
ENST00000530591.1
ENST00000534083.1 |
ST3GAL4
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
| chr19_+_54371114 | 1.95 |
ENST00000448420.1
ENST00000439000.1 ENST00000391770.4 ENST00000391771.1 |
MYADM
|
myeloid-associated differentiation marker |
| chr2_-_241396106 | 1.94 |
ENST00000404891.1
|
AC110619.2
|
Uncharacterized protein |
| chr10_-_15210615 | 1.94 |
ENST00000378150.1
|
NMT2
|
N-myristoyltransferase 2 |
| chr16_-_85784634 | 1.93 |
ENST00000284245.4
ENST00000602914.1 |
C16orf74
|
chromosome 16 open reading frame 74 |
| chr19_-_14201507 | 1.92 |
ENST00000533683.2
|
SAMD1
|
sterile alpha motif domain containing 1 |
| chr6_+_43739697 | 1.92 |
ENST00000230480.6
|
VEGFA
|
vascular endothelial growth factor A |
| chr10_-_134145321 | 1.91 |
ENST00000368625.4
ENST00000368619.3 ENST00000456004.1 ENST00000368620.2 |
STK32C
|
serine/threonine kinase 32C |
| chr1_+_44401479 | 1.91 |
ENST00000438616.3
|
ARTN
|
artemin |
| chr10_-_133795416 | 1.91 |
ENST00000540159.1
ENST00000368636.4 |
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3 |
| chr16_-_89007491 | 1.90 |
ENST00000327483.5
ENST00000564416.1 |
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
| chr1_+_182992545 | 1.89 |
ENST00000258341.4
|
LAMC1
|
laminin, gamma 1 (formerly LAMB2) |
| chr1_-_85358850 | 1.88 |
ENST00000370611.3
|
LPAR3
|
lysophosphatidic acid receptor 3 |
| chr1_-_204121013 | 1.88 |
ENST00000367201.3
|
ETNK2
|
ethanolamine kinase 2 |
| chr1_+_3370990 | 1.88 |
ENST00000378378.4
|
ARHGEF16
|
Rho guanine nucleotide exchange factor (GEF) 16 |
| chr7_+_48128816 | 1.87 |
ENST00000395564.4
|
UPP1
|
uridine phosphorylase 1 |
| chr9_-_139891165 | 1.87 |
ENST00000494426.1
|
CLIC3
|
chloride intracellular channel 3 |
| chr12_+_7023735 | 1.87 |
ENST00000538763.1
ENST00000544774.1 ENST00000545045.2 |
ENO2
|
enolase 2 (gamma, neuronal) |
| chr7_-_143059780 | 1.86 |
ENST00000409578.1
ENST00000409346.1 |
FAM131B
|
family with sequence similarity 131, member B |
| chr9_+_103189405 | 1.85 |
ENST00000395067.2
|
MSANTD3
|
Myb/SANT-like DNA-binding domain containing 3 |
| chr18_-_28681950 | 1.85 |
ENST00000251081.6
|
DSC2
|
desmocollin 2 |
| chr16_-_90085824 | 1.85 |
ENST00000002501.6
|
DBNDD1
|
dysbindin (dystrobrevin binding protein 1) domain containing 1 |
| chr12_+_7023491 | 1.83 |
ENST00000541477.1
ENST00000229277.1 |
ENO2
|
enolase 2 (gamma, neuronal) |
| chr16_-_46864955 | 1.83 |
ENST00000565112.1
|
C16orf87
|
chromosome 16 open reading frame 87 |
| chr10_+_76871229 | 1.83 |
ENST00000372690.3
|
SAMD8
|
sterile alpha motif domain containing 8 |
| chr17_+_17942684 | 1.82 |
ENST00000376345.3
|
GID4
|
GID complex subunit 4 |
| chr2_-_224903995 | 1.82 |
ENST00000409304.1
ENST00000454956.1 ENST00000258405.4 |
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
| chr8_-_142011316 | 1.82 |
ENST00000522684.1
ENST00000395218.2 ENST00000524357.1 ENST00000521332.1 ENST00000524040.1 ENST00000519881.1 ENST00000520045.1 |
PTK2
|
protein tyrosine kinase 2 |
| chr9_-_115095851 | 1.82 |
ENST00000343327.2
|
PTBP3
|
polypyrimidine tract binding protein 3 |
| chr7_-_128045984 | 1.82 |
ENST00000470772.1
ENST00000480861.1 ENST00000496200.1 |
IMPDH1
|
IMP (inosine 5'-monophosphate) dehydrogenase 1 |
| chrX_-_153602991 | 1.81 |
ENST00000369850.3
ENST00000422373.1 |
FLNA
|
filamin A, alpha |
| chr18_+_56530794 | 1.81 |
ENST00000590285.1
ENST00000586085.1 ENST00000589288.1 |
ZNF532
|
zinc finger protein 532 |
| chrX_-_107018969 | 1.79 |
ENST00000372383.4
|
TSC22D3
|
TSC22 domain family, member 3 |
| chr2_-_110371720 | 1.79 |
ENST00000356688.4
|
SEPT10
|
septin 10 |
| chr19_-_51472222 | 1.78 |
ENST00000376851.3
|
KLK6
|
kallikrein-related peptidase 6 |
| chr12_+_70760056 | 1.77 |
ENST00000258111.4
|
KCNMB4
|
potassium large conductance calcium-activated channel, subfamily M, beta member 4 |
| chr11_-_67981046 | 1.77 |
ENST00000402789.1
ENST00000402185.2 ENST00000458496.1 |
SUV420H1
|
suppressor of variegation 4-20 homolog 1 (Drosophila) |
| chr2_+_54683419 | 1.76 |
ENST00000356805.4
|
SPTBN1
|
spectrin, beta, non-erythrocytic 1 |
| chr14_+_55033815 | 1.76 |
ENST00000554335.1
|
SAMD4A
|
sterile alpha motif domain containing 4A |
| chr6_-_2903514 | 1.75 |
ENST00000380698.4
|
SERPINB9
|
serpin peptidase inhibitor, clade B (ovalbumin), member 9 |
| chr10_+_3109695 | 1.75 |
ENST00000381125.4
|
PFKP
|
phosphofructokinase, platelet |
| chr1_-_6479963 | 1.75 |
ENST00000377836.4
ENST00000487437.1 ENST00000489730.1 ENST00000377834.4 |
HES2
|
hes family bHLH transcription factor 2 |
| chr2_+_204193129 | 1.75 |
ENST00000417864.1
|
ABI2
|
abl-interactor 2 |
| chr17_+_79989937 | 1.74 |
ENST00000580965.1
|
RAC3
|
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
| chr17_+_42081914 | 1.74 |
ENST00000293404.3
ENST00000589767.1 |
NAGS
|
N-acetylglutamate synthase |
| chr17_+_30593195 | 1.73 |
ENST00000431505.2
ENST00000269051.4 ENST00000538145.1 |
RHBDL3
|
rhomboid, veinlet-like 3 (Drosophila) |
| chr9_+_131182697 | 1.73 |
ENST00000372838.4
ENST00000411852.1 |
CERCAM
|
cerebral endothelial cell adhesion molecule |
| chr6_+_151561506 | 1.73 |
ENST00000253332.1
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
| chr19_-_15344243 | 1.72 |
ENST00000602233.1
|
EPHX3
|
epoxide hydrolase 3 |
| chr22_-_37915247 | 1.72 |
ENST00000251973.5
|
CARD10
|
caspase recruitment domain family, member 10 |
| chr7_-_45128472 | 1.72 |
ENST00000490531.2
|
NACAD
|
NAC alpha domain containing |
| chr5_-_77944648 | 1.71 |
ENST00000380345.2
|
LHFPL2
|
lipoma HMGIC fusion partner-like 2 |
| chr22_-_41985865 | 1.70 |
ENST00000216259.7
|
PMM1
|
phosphomannomutase 1 |
| chr19_+_6531010 | 1.70 |
ENST00000245817.3
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9 |
| chr2_+_204193149 | 1.70 |
ENST00000422511.2
|
ABI2
|
abl-interactor 2 |
| chr22_+_31489344 | 1.69 |
ENST00000404574.1
|
SMTN
|
smoothelin |
| chr22_+_50609150 | 1.69 |
ENST00000159647.5
ENST00000395842.2 |
PANX2
|
pannexin 2 |
| chr21_-_40685536 | 1.69 |
ENST00000341322.4
|
BRWD1
|
bromodomain and WD repeat domain containing 1 |
| chr6_+_86159765 | 1.68 |
ENST00000369646.3
ENST00000257770.3 |
NT5E
|
5'-nucleotidase, ecto (CD73) |
| chr3_-_53290016 | 1.68 |
ENST00000423525.2
ENST00000423516.1 ENST00000296289.6 ENST00000462138.1 |
TKT
|
transketolase |
| chr2_-_10220538 | 1.68 |
ENST00000381813.4
|
CYS1
|
cystin 1 |
| chr15_-_70388943 | 1.68 |
ENST00000559048.1
ENST00000560939.1 ENST00000440567.3 ENST00000557907.1 ENST00000558379.1 ENST00000451782.2 ENST00000559929.1 |
TLE3
|
transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila) |
| chr11_+_43964055 | 1.67 |
ENST00000528572.1
|
C11orf96
|
chromosome 11 open reading frame 96 |
| chr10_-_79397479 | 1.67 |
ENST00000404771.3
|
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
| chr6_-_105627735 | 1.66 |
ENST00000254765.3
|
POPDC3
|
popeye domain containing 3 |
| chr12_-_124018252 | 1.66 |
ENST00000376874.4
|
RILPL1
|
Rab interacting lysosomal protein-like 1 |
| chr12_-_48152853 | 1.65 |
ENST00000171000.4
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
| chr8_+_22022223 | 1.65 |
ENST00000306385.5
|
BMP1
|
bone morphogenetic protein 1 |
Network of associatons between targets according to the STRING database.
First level regulatory network of WT1_MTF1_ZBTB7B
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.0 | 14.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 1.7 | 5.2 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
| 1.4 | 4.3 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 1.4 | 4.3 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
| 1.4 | 1.4 | GO:1900756 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
| 1.4 | 4.2 | GO:0042938 | dipeptide transport(GO:0042938) |
| 1.4 | 4.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 1.4 | 4.2 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 1.4 | 5.5 | GO:0006218 | uridine catabolic process(GO:0006218) |
| 1.4 | 4.1 | GO:2001035 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 1.3 | 3.9 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 1.1 | 1.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 1.0 | 6.2 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 1.0 | 3.1 | GO:1903572 | coronary vein morphogenesis(GO:0003169) regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 1.0 | 4.0 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 1.0 | 2.0 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
| 1.0 | 3.8 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 0.9 | 2.8 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 0.9 | 0.9 | GO:0072102 | glomerulus morphogenesis(GO:0072102) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.9 | 10.3 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 0.9 | 3.7 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.9 | 0.9 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.9 | 5.6 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 0.9 | 4.6 | GO:0097102 | vestibulocochlear nerve structural organization(GO:0021649) neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) endothelial tip cell fate specification(GO:0097102) positive regulation of retinal ganglion cell axon guidance(GO:1902336) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.9 | 3.6 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 0.9 | 2.7 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.9 | 8.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.9 | 2.7 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
| 0.9 | 5.3 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.9 | 2.6 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 0.9 | 2.6 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 0.9 | 1.7 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.9 | 2.6 | GO:2000412 | activation of MAPK activity involved in innate immune response(GO:0035419) positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) positive regulation of thymocyte migration(GO:2000412) |
| 0.8 | 2.5 | GO:0006154 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
| 0.8 | 5.0 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.8 | 0.8 | GO:1902882 | regulation of response to oxidative stress(GO:1902882) |
| 0.8 | 2.4 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 0.8 | 3.2 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.8 | 1.6 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.8 | 6.3 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.8 | 3.9 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 0.8 | 0.8 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
| 0.8 | 3.1 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
| 0.8 | 2.3 | GO:0015728 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 0.8 | 3.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.8 | 0.8 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
| 0.8 | 2.3 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 0.8 | 4.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.8 | 3.0 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.8 | 9.1 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.7 | 3.7 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.7 | 7.4 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.7 | 2.2 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 0.7 | 2.1 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.7 | 6.9 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.7 | 4.1 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.7 | 0.7 | GO:0014740 | negative regulation of muscle hyperplasia(GO:0014740) |
| 0.7 | 2.7 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.7 | 4.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.7 | 2.0 | GO:0097187 | dentinogenesis(GO:0097187) |
| 0.7 | 2.7 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 0.7 | 4.6 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.6 | 0.6 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
| 0.6 | 2.5 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.6 | 0.6 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.6 | 1.9 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.6 | 3.7 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 0.6 | 4.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.6 | 3.0 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.6 | 0.6 | GO:0046102 | inosine metabolic process(GO:0046102) |
| 0.6 | 6.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.6 | 1.7 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.6 | 1.7 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.6 | 0.6 | GO:1900195 | positive regulation of oocyte maturation(GO:1900195) |
| 0.6 | 1.7 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 0.6 | 1.7 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.6 | 0.6 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 0.6 | 1.7 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 0.5 | 2.7 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
| 0.5 | 3.8 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.5 | 1.6 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
| 0.5 | 4.8 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.5 | 2.7 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.5 | 4.8 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.5 | 1.6 | GO:0050894 | determination of affect(GO:0050894) |
| 0.5 | 2.7 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.5 | 1.6 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
| 0.5 | 0.5 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.5 | 2.6 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.5 | 2.1 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.5 | 6.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.5 | 2.6 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
| 0.5 | 3.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.5 | 8.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.5 | 2.0 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
| 0.5 | 1.5 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
| 0.5 | 1.5 | GO:2000538 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 0.5 | 2.0 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
| 0.5 | 1.5 | GO:0060178 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.5 | 2.0 | GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.5 | 0.5 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
| 0.5 | 2.5 | GO:0007068 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 0.5 | 0.5 | GO:0046108 | uridine metabolic process(GO:0046108) |
| 0.5 | 1.5 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.5 | 1.5 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.5 | 1.5 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.5 | 1.0 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.5 | 2.4 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
| 0.5 | 1.4 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
| 0.5 | 1.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.5 | 1.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.5 | 0.5 | GO:0051125 | regulation of actin nucleation(GO:0051125) |
| 0.5 | 1.9 | GO:0036116 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.5 | 1.9 | GO:1990869 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
| 0.5 | 1.4 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 0.5 | 2.8 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 0.5 | 1.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.5 | 2.3 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 0.5 | 1.4 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.5 | 0.9 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 0.5 | 4.1 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.5 | 2.3 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.5 | 0.5 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.5 | 1.4 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
| 0.5 | 4.5 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.5 | 4.1 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.4 | 2.2 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.4 | 2.7 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
| 0.4 | 1.3 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.4 | 1.8 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.4 | 2.2 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.4 | 1.3 | GO:1902869 | regulation of amacrine cell differentiation(GO:1902869) |
| 0.4 | 4.4 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 0.4 | 1.3 | GO:0048627 | myoblast development(GO:0048627) |
| 0.4 | 2.7 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.4 | 1.8 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.4 | 1.3 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
| 0.4 | 0.9 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 0.4 | 0.9 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.4 | 4.8 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.4 | 2.2 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
| 0.4 | 9.4 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.4 | 0.9 | GO:0010899 | regulation of phosphatidylcholine catabolic process(GO:0010899) |
| 0.4 | 1.3 | GO:1901628 | positive regulation of postsynaptic membrane organization(GO:1901628) positive regulation of receptor clustering(GO:1903911) |
| 0.4 | 2.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.4 | 0.9 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.4 | 1.7 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.4 | 2.5 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
| 0.4 | 1.3 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 0.4 | 12.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.4 | 1.3 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.4 | 5.4 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
| 0.4 | 1.2 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.4 | 0.4 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.4 | 10.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.4 | 6.1 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.4 | 1.6 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.4 | 1.2 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
| 0.4 | 2.4 | GO:0071321 | cellular response to cGMP(GO:0071321) |
| 0.4 | 2.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.4 | 2.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.4 | 10.4 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.4 | 5.6 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
| 0.4 | 1.2 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.4 | 1.2 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
| 0.4 | 0.4 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.4 | 2.8 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 0.4 | 3.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.4 | 1.6 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 0.4 | 1.6 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.4 | 1.2 | GO:0086098 | angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
| 0.4 | 3.1 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.4 | 0.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.4 | 1.5 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.4 | 2.3 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.4 | 2.3 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.4 | 1.5 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.4 | 0.8 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.4 | 1.1 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.4 | 1.5 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
| 0.4 | 3.7 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.4 | 1.1 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.4 | 0.4 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.4 | 1.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
| 0.4 | 0.4 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.4 | 1.8 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.4 | 2.9 | GO:0015705 | iodide transport(GO:0015705) |
| 0.4 | 1.1 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.4 | 0.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.4 | 1.4 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.4 | 0.4 | GO:2000410 | regulation of thymocyte migration(GO:2000410) |
| 0.4 | 1.4 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 0.4 | 0.7 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 0.4 | 1.1 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
| 0.4 | 5.6 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.3 | 0.3 | GO:0034109 | homotypic cell-cell adhesion(GO:0034109) |
| 0.3 | 0.3 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
| 0.3 | 1.0 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
| 0.3 | 5.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.3 | 4.5 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.3 | 1.4 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.3 | 3.1 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.3 | 1.0 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.3 | 0.3 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.3 | 1.0 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
| 0.3 | 1.0 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.3 | 1.4 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.3 | 0.3 | GO:0007521 | muscle cell fate determination(GO:0007521) |
| 0.3 | 3.1 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 0.3 | 1.7 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.3 | 1.3 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.3 | 2.7 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
| 0.3 | 5.0 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.3 | 1.7 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.3 | 0.3 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 0.3 | 0.7 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
| 0.3 | 2.7 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 0.3 | 0.3 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.3 | 1.0 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.3 | 2.3 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.3 | 2.0 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 0.3 | 3.6 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.3 | 1.0 | GO:1901993 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.3 | 1.0 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 0.3 | 0.3 | GO:0050807 | regulation of synapse organization(GO:0050807) |
| 0.3 | 1.3 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.3 | 5.2 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.3 | 0.3 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.3 | 1.6 | GO:0030047 | actin modification(GO:0030047) |
| 0.3 | 1.0 | GO:1901656 | glycoside transport(GO:1901656) |
| 0.3 | 1.6 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.3 | 4.9 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
| 0.3 | 1.0 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 0.3 | 0.6 | GO:0070836 | caveola assembly(GO:0070836) |
| 0.3 | 1.6 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.3 | 1.9 | GO:0009099 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.3 | 0.3 | GO:0072025 | distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) |
| 0.3 | 1.3 | GO:0070384 | Harderian gland development(GO:0070384) |
| 0.3 | 1.2 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 0.3 | 0.6 | GO:0010165 | response to X-ray(GO:0010165) |
| 0.3 | 1.2 | GO:0070982 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.3 | 0.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.3 | 0.3 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
| 0.3 | 0.3 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.3 | 0.3 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
| 0.3 | 1.2 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.3 | 1.2 | GO:1904647 | response to rotenone(GO:1904647) |
| 0.3 | 0.9 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
| 0.3 | 0.9 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.3 | 0.3 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.3 | 3.0 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.3 | 0.3 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
| 0.3 | 1.2 | GO:0046061 | dATP catabolic process(GO:0046061) |
| 0.3 | 0.6 | GO:1904172 | regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
| 0.3 | 1.2 | GO:0071484 | cellular response to light intensity(GO:0071484) |
| 0.3 | 1.2 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.3 | 2.1 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.3 | 0.3 | GO:1905166 | negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 0.3 | 1.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.3 | 2.7 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.3 | 1.5 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.3 | 1.2 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) |
| 0.3 | 0.3 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.3 | 1.1 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.3 | 1.7 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.3 | 1.4 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
| 0.3 | 1.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.3 | 0.6 | GO:0021622 | oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 0.3 | 2.0 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.3 | 0.3 | GO:0051198 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.3 | 0.8 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.3 | 1.7 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.3 | 0.3 | GO:0003416 | endochondral bone growth(GO:0003416) |
| 0.3 | 1.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.3 | 1.7 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.3 | 0.8 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.3 | 1.1 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.3 | 1.1 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
| 0.3 | 1.4 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
| 0.3 | 0.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.3 | 0.3 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.3 | 1.9 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.3 | 1.4 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.3 | 0.5 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
| 0.3 | 1.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 0.3 | 0.8 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.3 | 1.3 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.3 | 3.5 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.3 | 1.3 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.3 | 2.7 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
| 0.3 | 0.3 | GO:0002543 | activation of blood coagulation via clotting cascade(GO:0002543) |
| 0.3 | 2.4 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.3 | 0.8 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.3 | 0.8 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 0.3 | 1.6 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.3 | 1.3 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.3 | 6.7 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.3 | 3.3 | GO:0009629 | response to gravity(GO:0009629) |
| 0.3 | 2.8 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.3 | 2.0 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 0.3 | 1.8 | GO:0043622 | cortical microtubule organization(GO:0043622) |
| 0.3 | 0.8 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.3 | 1.3 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.3 | 1.0 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.2 | 0.5 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.2 | 5.0 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
| 0.2 | 1.0 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.2 | 2.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.2 | 0.5 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.2 | 5.6 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.2 | 0.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
| 0.2 | 0.7 | GO:1902910 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of transforming growth factor beta2 production(GO:0032912) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 0.2 | 11.8 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) |
| 0.2 | 1.7 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.2 | 2.2 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
| 0.2 | 0.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.2 | 0.2 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.2 | 1.0 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
| 0.2 | 1.0 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.2 | 0.7 | GO:0070141 | response to UV-A(GO:0070141) |
| 0.2 | 0.5 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
| 0.2 | 5.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.2 | 0.7 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.2 | 3.8 | GO:0051608 | histamine transport(GO:0051608) |
| 0.2 | 1.9 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.2 | 1.9 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.2 | 0.5 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.2 | 1.2 | GO:0003343 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
| 0.2 | 1.2 | GO:0035564 | regulation of kidney size(GO:0035564) |
| 0.2 | 0.2 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.2 | 1.2 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.2 | 1.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.2 | 1.4 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.2 | 1.2 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.2 | 3.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.2 | 0.2 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
| 0.2 | 1.4 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.2 | 0.5 | GO:0007622 | rhythmic behavior(GO:0007622) |
| 0.2 | 0.7 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.2 | 0.7 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
| 0.2 | 1.8 | GO:0046618 | drug export(GO:0046618) |
| 0.2 | 0.9 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 0.2 | 0.7 | GO:0071504 | cellular response to heparin(GO:0071504) |
| 0.2 | 1.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.2 | 0.7 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
| 0.2 | 0.7 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.2 | 0.9 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 0.2 | 0.7 | GO:1904482 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 0.2 | 0.7 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
| 0.2 | 2.7 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.2 | 0.2 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.2 | 0.7 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.2 | 0.9 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
| 0.2 | 0.4 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
| 0.2 | 1.1 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
| 0.2 | 0.7 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.2 | 0.4 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.2 | 1.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.2 | 0.9 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
| 0.2 | 0.7 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.2 | 3.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.2 | 1.3 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
| 0.2 | 1.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.2 | 1.7 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.2 | 1.7 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.2 | 1.7 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 0.2 | 0.7 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
| 0.2 | 0.7 | GO:0035854 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.2 | 0.2 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.2 | 1.5 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 0.2 | 2.1 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.2 | 2.8 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.2 | 1.3 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.2 | 2.1 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.2 | 0.8 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.2 | 0.4 | GO:0072014 | proximal tubule development(GO:0072014) |
| 0.2 | 0.2 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.2 | 1.1 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.2 | 1.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.2 | 0.6 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
| 0.2 | 2.9 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.2 | 2.3 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.2 | 0.6 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 0.2 | 3.4 | GO:0033622 | integrin activation(GO:0033622) |
| 0.2 | 0.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
| 0.2 | 2.3 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.2 | 0.8 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.2 | 0.2 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
| 0.2 | 0.6 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.2 | 1.7 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.2 | 2.5 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.2 | 0.6 | GO:0034963 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.2 | 0.4 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.2 | 1.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.2 | 4.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.2 | 1.4 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
| 0.2 | 4.1 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.2 | 1.8 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
| 0.2 | 1.6 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.2 | 2.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.2 | 0.6 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 0.2 | 0.2 | GO:0070305 | response to cGMP(GO:0070305) |
| 0.2 | 0.2 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.2 | 1.2 | GO:0060613 | fat pad development(GO:0060613) |
| 0.2 | 0.2 | GO:0006971 | hypotonic response(GO:0006971) |
| 0.2 | 0.6 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.2 | 0.4 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.2 | 0.4 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
| 0.2 | 2.8 | GO:0046051 | UTP metabolic process(GO:0046051) |
| 0.2 | 1.4 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.2 | 0.4 | GO:0006972 | hyperosmotic response(GO:0006972) |
| 0.2 | 0.8 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.2 | 0.2 | GO:0010996 | response to auditory stimulus(GO:0010996) |
| 0.2 | 0.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.2 | 3.6 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
| 0.2 | 0.4 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
| 0.2 | 1.6 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.2 | 1.0 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.2 | 1.2 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.2 | 0.6 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.2 | 1.2 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.2 | 1.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.2 | 1.2 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.2 | 0.4 | GO:0090317 | negative regulation of intracellular protein transport(GO:0090317) |
| 0.2 | 0.6 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.2 | 0.2 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.2 | 1.5 | GO:0046078 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
| 0.2 | 1.0 | GO:0015862 | uridine transport(GO:0015862) |
| 0.2 | 1.9 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.2 | 1.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.2 | 0.8 | GO:0021564 | vagus nerve development(GO:0021564) |
| 0.2 | 0.2 | GO:0001967 | suckling behavior(GO:0001967) |
| 0.2 | 1.9 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.2 | 1.5 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.2 | 3.4 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.2 | 0.2 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.2 | 1.5 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.2 | 1.1 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
| 0.2 | 1.1 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.2 | 0.7 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
| 0.2 | 3.9 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.2 | 0.7 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.2 | 2.8 | GO:0030540 | female genitalia development(GO:0030540) |
| 0.2 | 2.0 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 | 2.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.2 | 0.9 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.2 | 0.5 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.2 | 5.1 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
| 0.2 | 2.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.2 | 0.9 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.2 | 0.4 | GO:0071336 | submandibular salivary gland formation(GO:0060661) hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 0.2 | 1.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.2 | 2.7 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
| 0.2 | 0.2 | GO:0021553 | olfactory nerve development(GO:0021553) |
| 0.2 | 0.7 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.2 | 0.7 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.2 | 3.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.2 | 1.9 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.2 | 0.9 | GO:0048749 | compound eye development(GO:0048749) |
| 0.2 | 0.5 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 0.2 | 0.2 | GO:0071306 | cellular response to vitamin E(GO:0071306) |
| 0.2 | 0.4 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.2 | 0.7 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.2 | 3.7 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
| 0.2 | 1.4 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.2 | 1.6 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.2 | 0.9 | GO:0016129 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.2 | 0.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.2 | 0.2 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
| 0.2 | 3.7 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.2 | 1.6 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.2 | 0.5 | GO:0070631 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.2 | 0.2 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
| 0.2 | 0.3 | GO:0071373 | cellular response to luteinizing hormone stimulus(GO:0071373) |
| 0.2 | 0.9 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.2 | 0.5 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
| 0.2 | 0.9 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.2 | 0.9 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.2 | 3.8 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.2 | 0.2 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
| 0.2 | 0.5 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 0.2 | 0.5 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.2 | 6.7 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.2 | 0.5 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.2 | 1.2 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.2 | 0.2 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
| 0.2 | 0.3 | GO:0071622 | regulation of granulocyte chemotaxis(GO:0071622) |
| 0.2 | 1.7 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.2 | 2.0 | GO:0099639 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
| 0.2 | 0.2 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
| 0.2 | 3.9 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.2 | 0.2 | GO:0060374 | mast cell differentiation(GO:0060374) |
| 0.2 | 0.5 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.2 | 0.2 | GO:0032425 | positive regulation of mismatch repair(GO:0032425) |
| 0.2 | 0.3 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.2 | 0.6 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.2 | 0.5 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
| 0.2 | 0.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.2 | 1.0 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.2 | 0.5 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 0.2 | 0.6 | GO:0048339 | paraxial mesoderm development(GO:0048339) |
| 0.2 | 0.3 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
| 0.2 | 0.5 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.2 | 0.2 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 0.2 | 0.6 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 0.2 | 0.2 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.2 | 1.0 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.2 | 0.8 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 0.2 | 0.2 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.2 | 0.6 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
| 0.2 | 1.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.2 | 0.5 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
| 0.2 | 0.2 | GO:0000303 | response to superoxide(GO:0000303) |
| 0.2 | 0.6 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.2 | 0.6 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.2 | 1.1 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
| 0.2 | 0.2 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
| 0.2 | 0.6 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.2 | 0.3 | GO:0006007 | glucose catabolic process(GO:0006007) |
| 0.2 | 0.6 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.2 | 0.6 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.2 | 0.3 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.2 | 0.5 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.2 | 3.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.2 | 0.3 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.2 | 0.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.2 | 0.5 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.2 | 2.3 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.2 | 0.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.2 | 0.2 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.2 | 0.3 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) regulation of transforming growth factor-beta secretion(GO:2001201) |
| 0.2 | 0.8 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.2 | 0.3 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
| 0.2 | 0.8 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.1 | 0.3 | GO:0003285 | septum secundum development(GO:0003285) |
| 0.1 | 0.7 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.1 | 1.8 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.1 | 0.1 | GO:1904760 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 0.1 | 0.6 | GO:0042853 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.1 | 0.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 | 0.7 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
| 0.1 | 0.3 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 0.1 | 0.7 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.1 | 1.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.1 | 0.3 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 0.1 | 0.1 | GO:0051216 | cartilage development(GO:0051216) |
| 0.1 | 0.9 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.1 | 0.7 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.1 | 0.7 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.1 | 2.2 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 | 0.4 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
| 0.1 | 0.1 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
| 0.1 | 1.3 | GO:0015871 | choline transport(GO:0015871) |
| 0.1 | 1.3 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.1 | 0.1 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.1 | 1.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.1 | 0.9 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
| 0.1 | 1.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.1 | 1.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
| 0.1 | 0.4 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.1 | 1.1 | GO:0030578 | PML body organization(GO:0030578) |
| 0.1 | 0.8 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.1 | 1.0 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 0.1 | 0.3 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
| 0.1 | 0.6 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 | 0.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.1 | 1.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
| 0.1 | 0.1 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
| 0.1 | 0.4 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.1 | 0.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 | 0.4 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.1 | 0.4 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 0.1 | 0.8 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.1 | 4.0 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.1 | 0.3 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
| 0.1 | 0.7 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.1 | 0.3 | GO:0060488 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.1 | 0.4 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 0.1 | 0.7 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.1 | 0.1 | GO:1902668 | negative regulation of axon guidance(GO:1902668) |
| 0.1 | 0.7 | GO:0001712 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.1 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.1 | 0.4 | GO:0003383 | apical constriction(GO:0003383) |
| 0.1 | 3.0 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.1 | 0.3 | GO:0070859 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
| 0.1 | 0.5 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
| 0.1 | 0.3 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.1 | 0.7 | GO:0031622 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
| 0.1 | 0.1 | GO:0048483 | autonomic nervous system development(GO:0048483) |
| 0.1 | 0.7 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
| 0.1 | 0.8 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.1 | 0.3 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.1 | 0.7 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.1 | 0.7 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.1 | 0.4 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
| 0.1 | 0.8 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 | 0.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 | 0.1 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.1 | 0.1 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.1 | 1.7 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.1 | 0.6 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.1 | 0.9 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.1 | 0.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 | 1.0 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.1 | 0.3 | GO:0051828 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
| 0.1 | 0.8 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.1 | 0.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.1 | 1.9 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.1 | 0.1 | GO:1902164 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.1 | 0.6 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 0.1 | 0.5 | GO:0072240 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
| 0.1 | 0.3 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.1 | 0.3 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.1 | 0.5 | GO:0060290 | transdifferentiation(GO:0060290) |
| 0.1 | 0.3 | GO:0072186 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) |
| 0.1 | 0.6 | GO:0032526 | response to retinoic acid(GO:0032526) |
| 0.1 | 2.0 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.1 | 0.2 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 0.1 | 0.6 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 0.1 | 0.4 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
| 0.1 | 0.2 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.1 | 1.9 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.1 | 0.6 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.1 | 0.2 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 0.1 | 0.2 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.1 | 0.4 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.1 | 0.2 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
| 0.1 | 1.0 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
| 0.1 | 1.5 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.1 | 0.2 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.1 | 1.3 | GO:0030091 | protein repair(GO:0030091) |
| 0.1 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 | 0.4 | GO:0045957 | regulation of complement activation, alternative pathway(GO:0030451) negative regulation of complement activation, alternative pathway(GO:0045957) |
| 0.1 | 0.7 | GO:0060976 | coronary vasculature development(GO:0060976) |
| 0.1 | 2.9 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 0.1 | 1.5 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.1 | 0.1 | GO:0001755 | neural crest cell migration(GO:0001755) |
| 0.1 | 1.6 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.1 | 0.5 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.1 | 0.8 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.1 | 0.5 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.1 | 0.1 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.1 | 0.4 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 | 1.8 | GO:0060841 | venous blood vessel development(GO:0060841) |
| 0.1 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.1 | 1.1 | GO:0001845 | phagolysosome assembly(GO:0001845) |
| 0.1 | 3.3 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.1 | 0.4 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.1 | 0.5 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.1 | 4.4 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
| 0.1 | 0.2 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.1 | 0.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 | 4.0 | GO:0097503 | sialylation(GO:0097503) |
| 0.1 | 0.4 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.1 | 1.3 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
| 0.1 | 0.3 | GO:0007538 | primary sex determination(GO:0007538) |
| 0.1 | 0.3 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.1 | 0.3 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
| 0.1 | 0.3 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 | 1.4 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.1 | 0.6 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.1 | 0.8 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 | 0.1 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.1 | 0.6 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.1 | 0.3 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
| 0.1 | 0.2 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
| 0.1 | 0.1 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
| 0.1 | 0.1 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
| 0.1 | 3.1 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
| 0.1 | 0.3 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.1 | 0.6 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.1 | 5.7 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.1 | 0.6 | GO:0000022 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) |
| 0.1 | 0.6 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 0.1 | 0.2 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
| 0.1 | 0.2 | GO:1903991 | regulation of T cell antigen processing and presentation(GO:0002625) positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) negative regulation of CD8-positive, alpha-beta T cell activation(GO:2001186) |
| 0.1 | 0.3 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.1 | 1.6 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.1 | 0.3 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.1 | 0.4 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.1 | 2.2 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 0.1 | 2.3 | GO:0090505 | wound healing, spreading of cells(GO:0044319) epiboly involved in wound healing(GO:0090505) |
| 0.1 | 1.9 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.1 | 0.3 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.1 | 1.1 | GO:0015074 | DNA integration(GO:0015074) |
| 0.1 | 0.7 | GO:1901909 | diadenosine polyphosphate metabolic process(GO:0015959) diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.1 | 3.3 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.1 | 0.3 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
| 0.1 | 0.4 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
| 0.1 | 0.6 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.1 | 0.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 | 0.7 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
| 0.1 | 0.1 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
| 0.1 | 0.2 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
| 0.1 | 0.3 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.1 | 0.1 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
| 0.1 | 5.2 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
| 0.1 | 0.4 | GO:0003335 | corneocyte development(GO:0003335) |
| 0.1 | 0.3 | GO:0060264 | respiratory burst involved in inflammatory response(GO:0002536) regulation of respiratory burst involved in inflammatory response(GO:0060264) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
| 0.1 | 0.3 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.1 | 0.3 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.1 | 0.2 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.1 | 4.7 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
| 0.1 | 0.4 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
| 0.1 | 0.5 | GO:0051414 | response to cortisol(GO:0051414) |
| 0.1 | 0.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.1 | 0.1 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.1 | 0.3 | GO:0035624 | receptor transactivation(GO:0035624) |
| 0.1 | 0.6 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.1 | 0.4 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.1 | 0.9 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.1 | 0.9 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.1 | 0.8 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.1 | 1.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 | 0.7 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.1 | 0.2 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
| 0.1 | 0.3 | GO:0070988 | demethylation(GO:0070988) |
| 0.1 | 0.6 | GO:0001946 | lymphangiogenesis(GO:0001946) |
| 0.1 | 0.4 | GO:0031296 | B cell costimulation(GO:0031296) |
| 0.1 | 0.2 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
| 0.1 | 0.4 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.1 | 0.4 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.1 | 0.5 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 | 0.6 | GO:0048565 | digestive tract development(GO:0048565) |
| 0.1 | 0.5 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.1 | 0.3 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
| 0.1 | 0.4 | GO:0085032 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.1 | 0.1 | GO:0032095 | regulation of response to food(GO:0032095) |
| 0.1 | 0.4 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 | 0.1 | GO:0014855 | striated muscle cell proliferation(GO:0014855) |
| 0.1 | 0.1 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) |
| 0.1 | 0.9 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 | 0.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.1 | 0.5 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
| 0.1 | 0.1 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 | 0.2 | GO:0032272 | negative regulation of protein polymerization(GO:0032272) |
| 0.1 | 0.2 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.1 | 1.2 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
| 0.1 | 0.1 | GO:0010193 | response to ozone(GO:0010193) |
| 0.1 | 3.9 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.1 | 0.8 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.1 | 0.3 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) |
| 0.1 | 0.2 | GO:0060326 | cell chemotaxis(GO:0060326) |
| 0.1 | 0.2 | GO:0034201 | response to oleic acid(GO:0034201) |
| 0.1 | 0.7 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.1 | 0.2 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.1 | 1.3 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.1 | 0.3 | GO:0007343 | egg activation(GO:0007343) |
| 0.1 | 0.1 | GO:0099612 | protein localization to axon(GO:0099612) |
| 0.1 | 0.8 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 0.1 | 1.3 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 0.1 | 1.5 | GO:0042420 | dopamine catabolic process(GO:0042420) |
| 0.1 | 0.1 | GO:1904582 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
| 0.1 | 0.4 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 | 0.3 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
| 0.1 | 0.1 | GO:0048841 | regulation of axon extension involved in axon guidance(GO:0048841) |
| 0.1 | 0.2 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.1 | 0.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
| 0.1 | 0.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.1 | 2.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.1 | 0.2 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 0.1 | 0.2 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
| 0.1 | 1.5 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.1 | 0.1 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.1 | 0.3 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.1 | 1.1 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.1 | 0.2 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.1 | 0.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.1 | 0.3 | GO:0021854 | hypothalamus development(GO:0021854) |
| 0.1 | 1.2 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.1 | 0.4 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 0.1 | 0.1 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.1 | 0.1 | GO:0006565 | L-serine catabolic process(GO:0006565) |
| 0.1 | 0.2 | GO:0034698 | response to gonadotropin(GO:0034698) |
| 0.1 | 0.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 | 0.1 | GO:0060699 | regulation of endoribonuclease activity(GO:0060699) |
| 0.1 | 1.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.1 | 1.2 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
| 0.1 | 0.8 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.1 | 0.5 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.1 | 0.1 | GO:0001508 | action potential(GO:0001508) |
| 0.1 | 1.3 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.1 | 0.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 | 0.5 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 0.1 | 0.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
| 0.1 | 0.1 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 | 0.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.1 | 0.4 | GO:0035709 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.1 | 0.9 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
| 0.1 | 0.4 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.1 | 0.6 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.1 | 0.4 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.1 | 0.3 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.1 | 0.2 | GO:1900155 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.1 | 0.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 0.1 | 0.8 | GO:0097118 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 0.1 | 0.8 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.1 | 0.4 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.1 | 1.1 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 | 1.1 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 | 0.7 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
| 0.1 | 0.7 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.1 | 0.4 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.1 | 1.7 | GO:0001556 | oocyte maturation(GO:0001556) |
| 0.1 | 0.3 | GO:0030300 | negative regulation of intestinal phytosterol absorption(GO:0010949) regulation of intestinal cholesterol absorption(GO:0030300) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) regulation of intestinal lipid absorption(GO:1904729) negative regulation of intestinal lipid absorption(GO:1904730) |
| 0.1 | 0.8 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.1 | 0.3 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
| 0.1 | 0.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.1 | 0.1 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
| 0.1 | 0.2 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.1 | 0.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.1 | 1.8 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.1 | 0.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 0.1 | 1.3 | GO:0032196 | transposition(GO:0032196) |
| 0.1 | 0.5 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 | 0.8 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.1 | 1.4 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.1 | 0.5 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
| 0.1 | 5.6 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.1 | 0.8 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 | 0.2 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.1 | 2.7 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.1 | 0.7 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
| 0.1 | 0.8 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
| 0.1 | 0.4 | GO:0042220 | response to cocaine(GO:0042220) |
| 0.1 | 0.2 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
| 0.1 | 0.3 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.1 | 0.2 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.1 | 0.4 | GO:0035909 | aorta morphogenesis(GO:0035909) |
| 0.1 | 1.3 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.1 | 0.5 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.1 | 0.4 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.1 | 2.7 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
| 0.1 | 0.3 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
| 0.1 | 0.2 | GO:0090427 | activation of meiosis(GO:0090427) |
| 0.1 | 0.3 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.1 | 0.1 | GO:1901655 | cellular response to ketone(GO:1901655) |
| 0.1 | 0.5 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 0.1 | 0.3 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
| 0.1 | 1.0 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 | 2.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
| 0.1 | 0.1 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.1 | 0.7 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.1 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.1 | 0.3 | GO:1900145 | regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.1 | 0.2 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
| 0.1 | 0.5 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
| 0.1 | 0.3 | GO:0010629 | negative regulation of gene expression(GO:0010629) |
| 0.1 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.1 | 2.6 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
| 0.1 | 0.3 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.1 | 0.2 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
| 0.1 | 0.3 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 | 0.2 | GO:0035411 | catenin import into nucleus(GO:0035411) |
| 0.1 | 0.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.1 | 1.0 | GO:0030220 | platelet formation(GO:0030220) |
| 0.1 | 0.3 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.1 | 1.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.1 | 0.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 | 0.2 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.1 | 0.2 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.1 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
| 0.1 | 0.2 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
| 0.1 | 0.1 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
| 0.1 | 0.1 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 0.1 | 1.5 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) circadian sleep/wake cycle, sleep(GO:0050802) |
| 0.1 | 0.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
| 0.1 | 1.5 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.1 | 0.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.1 | 0.2 | GO:0001927 | exocyst assembly(GO:0001927) |
| 0.1 | 0.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.1 | 0.1 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.1 | 0.6 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.1 | 0.7 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 0.1 | 0.1 | GO:0048705 | skeletal system morphogenesis(GO:0048705) |
| 0.1 | 2.8 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
| 0.1 | 0.2 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) |
| 0.1 | 0.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 0.1 | 0.7 | GO:0001964 | startle response(GO:0001964) |
| 0.1 | 0.2 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.1 | 0.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 | 0.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.1 | 0.1 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 0.1 | 0.8 | GO:0048265 | response to pain(GO:0048265) |
| 0.1 | 0.3 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
| 0.1 | 0.3 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 | 0.1 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.1 | 0.4 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
| 0.1 | 0.6 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.1 | 1.4 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 | 0.7 | GO:0015816 | glycine transport(GO:0015816) |
| 0.1 | 0.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.1 | 6.0 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.1 | 4.4 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 | 0.5 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.1 | 0.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.1 | 3.4 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
| 0.1 | 0.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.1 | 1.9 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 | 0.2 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
| 0.1 | 0.9 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.1 | 0.3 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.1 | 0.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 | 1.0 | GO:0001893 | maternal placenta development(GO:0001893) |
| 0.1 | 0.2 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.1 | 0.2 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
| 0.1 | 0.2 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
| 0.1 | 0.2 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
| 0.1 | 0.1 | GO:0001759 | organ induction(GO:0001759) |
| 0.1 | 0.1 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.1 | 0.4 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
| 0.1 | 0.2 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.1 | 0.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.1 | 0.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
| 0.1 | 0.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 0.1 | 0.2 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.1 | 0.2 | GO:0002182 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.1 | 0.3 | GO:0015942 | formate metabolic process(GO:0015942) |
| 0.1 | 0.2 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
| 0.1 | 0.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.1 | 1.3 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.1 | 0.3 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.1 | 0.3 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
| 0.1 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.1 | 1.1 | GO:2000345 | regulation of hepatocyte proliferation(GO:2000345) |
| 0.1 | 0.3 | GO:2000170 | negative regulation of gap junction assembly(GO:1903597) positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.1 | 0.2 | GO:0071030 | nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
| 0.1 | 0.4 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.1 | 0.4 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.1 | 0.3 | GO:1902745 | positive regulation of lamellipodium organization(GO:1902745) |
| 0.1 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.1 | 0.4 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
| 0.1 | 0.2 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.1 | 0.2 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.1 | 0.4 | GO:0030261 | chromosome condensation(GO:0030261) |
| 0.1 | 0.1 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 0.1 | 0.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 | 0.3 | GO:0035137 | hindlimb morphogenesis(GO:0035137) |
| 0.1 | 0.3 | GO:1903412 | response to bile acid(GO:1903412) |
| 0.1 | 0.2 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
| 0.1 | 0.1 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
| 0.1 | 0.3 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.1 | 0.8 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 | 2.2 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.1 | 0.4 | GO:0030421 | defecation(GO:0030421) |
| 0.1 | 1.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.1 | 0.1 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
| 0.1 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 | 0.4 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
| 0.1 | 0.2 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
| 0.1 | 0.3 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.1 | 0.6 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
| 0.1 | 0.1 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.1 | 0.2 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 0.1 | 0.3 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
| 0.1 | 0.1 | GO:0051714 | positive regulation of cytolysis in other organism(GO:0051714) |
| 0.1 | 0.2 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
| 0.1 | 1.0 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.1 | 0.1 | GO:0015908 | fatty acid transport(GO:0015908) |
| 0.1 | 1.1 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.1 | 0.8 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 0.1 | 0.3 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.1 | 0.1 | GO:0036490 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) |
| 0.1 | 0.3 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.1 | 0.1 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.1 | 0.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.1 | 0.2 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
| 0.1 | 0.3 | GO:0046689 | response to mercury ion(GO:0046689) |
| 0.1 | 0.2 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 0.1 | 0.3 | GO:0001912 | positive regulation of leukocyte mediated cytotoxicity(GO:0001912) |
| 0.1 | 0.1 | GO:0090307 | mitotic spindle assembly(GO:0090307) |
| 0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.1 | 0.7 | GO:0009650 | UV protection(GO:0009650) |
| 0.1 | 0.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.1 | 0.3 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.1 | 0.8 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.1 | 2.7 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.1 | 0.3 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
| 0.1 | 0.2 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
| 0.1 | 2.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.1 | 0.7 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.1 | 1.3 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.1 | 0.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.1 | 2.4 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.1 | 1.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 0.1 | 0.9 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.1 | 1.1 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.1 | 0.5 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.1 | 0.6 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.1 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.1 | 0.2 | GO:0010042 | response to manganese ion(GO:0010042) |
| 0.1 | 0.3 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.1 | 0.1 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
| 0.1 | 0.8 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.1 | 0.4 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.1 | 0.3 | GO:0015803 | branched-chain amino acid transport(GO:0015803) |
| 0.1 | 0.1 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
| 0.1 | 0.2 | GO:0060065 | uterus development(GO:0060065) |
| 0.1 | 0.2 | GO:1902743 | regulation of lamellipodium organization(GO:1902743) |
| 0.1 | 0.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
| 0.1 | 0.3 | GO:0090175 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) regulation of establishment of planar polarity(GO:0090175) |
| 0.1 | 0.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 | 0.6 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
| 0.1 | 0.4 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
| 0.1 | 0.1 | GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
| 0.1 | 0.4 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.1 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
| 0.1 | 0.5 | GO:0045109 | intermediate filament organization(GO:0045109) |
| 0.1 | 0.3 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 0.1 | 0.3 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.1 | 0.2 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
| 0.1 | 0.1 | GO:0032098 | regulation of appetite(GO:0032098) |
| 0.1 | 0.2 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.1 | 0.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.1 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.1 | 0.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.1 | 0.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.1 | 0.3 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.1 | 0.2 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.1 | 0.2 | GO:0007528 | neuromuscular junction development(GO:0007528) |
| 0.1 | 0.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.1 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.1 | 0.3 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.1 | 1.0 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
| 0.1 | 0.1 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.1 | 1.3 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
| 0.1 | 0.5 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
| 0.1 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.1 | 0.6 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 | 0.5 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
| 0.1 | 0.2 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.1 | 0.1 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.1 | 0.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 1.3 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.1 | 0.1 | GO:0031579 | membrane raft organization(GO:0031579) |
| 0.1 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 | 0.1 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.1 | 2.6 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 | 0.9 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.1 | 0.9 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.1 | 0.5 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.1 | 0.8 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
| 0.1 | 0.4 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.1 | 0.1 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.1 | 0.2 | GO:0031112 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) |
| 0.1 | 0.1 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.1 | 0.1 | GO:0006534 | cysteine metabolic process(GO:0006534) |
| 0.1 | 0.8 | GO:0097435 | fibril organization(GO:0097435) |
| 0.1 | 1.3 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 0.2 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.1 | 0.3 | GO:1903972 | mammary gland fat development(GO:0060611) regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) regulation of response to macrophage colony-stimulating factor(GO:1903969) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of glial cell migration(GO:1903977) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) positive regulation of microglial cell migration(GO:1904141) |
| 0.1 | 0.7 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.1 | 0.1 | GO:0051665 | membrane raft localization(GO:0051665) |
| 0.1 | 0.2 | GO:0048016 | calcineurin-NFAT signaling cascade(GO:0033173) inositol phosphate-mediated signaling(GO:0048016) |
| 0.1 | 0.2 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.1 | 1.2 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
| 0.1 | 0.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.1 | 0.2 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.1 | 0.4 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
| 0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.1 | 0.1 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.1 | 0.5 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.1 | 0.7 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
| 0.1 | 0.1 | GO:1903350 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.1 | 0.2 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.1 | 0.3 | GO:0090042 | tubulin deacetylation(GO:0090042) |
| 0.1 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.1 | 0.1 | GO:0021626 | hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
| 0.1 | 0.3 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 0.1 | 0.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.1 | 0.7 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
| 0.1 | 1.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.1 | 0.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
| 0.1 | 0.2 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 0.1 | 0.6 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.1 | 1.2 | GO:0016032 | viral process(GO:0016032) |
| 0.1 | 0.4 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.1 | 0.7 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
| 0.1 | 0.1 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
| 0.1 | 0.3 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.1 | 0.3 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.1 | 0.7 | GO:0061436 | establishment of skin barrier(GO:0061436) |
| 0.1 | 2.0 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.0 | 0.5 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.0 | 0.5 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
| 0.0 | 0.0 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
| 0.0 | 3.1 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.0 | 1.8 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 0.0 | 0.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.0 | 0.7 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.0 | 1.9 | GO:0008088 | axo-dendritic transport(GO:0008088) |
| 0.0 | 3.6 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.0 | 0.1 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
| 0.0 | 0.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.0 | 0.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.0 | 0.2 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
| 0.0 | 0.3 | GO:1902572 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.0 | 0.2 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.0 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.0 | 0.1 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 0.0 | 0.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.0 | 1.6 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 | 0.1 | GO:0072575 | hepatocyte proliferation(GO:0072574) epithelial cell proliferation involved in liver morphogenesis(GO:0072575) |
| 0.0 | 0.5 | GO:0009304 | tRNA transcription(GO:0009304) |
| 0.0 | 0.2 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
| 0.0 | 0.1 | GO:0010458 | exit from mitosis(GO:0010458) |
| 0.0 | 0.5 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.0 | 0.3 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.0 | 0.4 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.0 | 0.0 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.0 | 2.2 | GO:0035036 | sperm-egg recognition(GO:0035036) |
| 0.0 | 0.2 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
| 0.0 | 0.0 | GO:0032417 | regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.0 | 0.3 | GO:0008037 | cell recognition(GO:0008037) |
| 0.0 | 0.0 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.0 | 0.4 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 0.0 | 0.2 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
| 0.0 | 0.8 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
| 0.0 | 0.0 | GO:0043650 | dicarboxylic acid biosynthetic process(GO:0043650) |
| 0.0 | 0.7 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
| 0.0 | 0.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
| 0.0 | 0.5 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.0 | 0.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.0 | 0.1 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
| 0.0 | 0.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.0 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.0 | 0.2 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.0 | 0.1 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.0 | 0.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 | 0.3 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
| 0.0 | 0.9 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.0 | 0.1 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
| 0.0 | 0.4 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.0 | 0.6 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.0 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
| 0.0 | 0.5 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
| 0.0 | 0.2 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
| 0.0 | 0.2 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.0 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.0 | 0.4 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.0 | 0.2 | GO:0048867 | ganglion mother cell fate determination(GO:0007402) stem cell fate determination(GO:0048867) |
| 0.0 | 0.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 0.0 | 0.1 | GO:0019835 | cytolysis(GO:0019835) |
| 0.0 | 2.1 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
| 0.0 | 0.2 | GO:0006970 | response to osmotic stress(GO:0006970) |
| 0.0 | 0.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 0.0 | 0.2 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.0 | 0.5 | GO:0006937 | regulation of muscle contraction(GO:0006937) |
| 0.0 | 0.3 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.0 | 1.8 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 | 0.0 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
| 0.0 | 0.2 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
| 0.0 | 0.3 | GO:0071806 | protein transmembrane transport(GO:0071806) |
| 0.0 | 0.1 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.0 | 0.2 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.0 | 0.6 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
| 0.0 | 0.1 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.0 | 0.1 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
| 0.0 | 0.2 | GO:0000187 | activation of MAPK activity(GO:0000187) |
| 0.0 | 0.3 | GO:0072319 | synaptic vesicle uncoating(GO:0016191) vesicle uncoating(GO:0072319) |
| 0.0 | 0.0 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
| 0.0 | 1.0 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.0 | 0.1 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.0 | 0.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.0 | 0.1 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
| 0.0 | 0.5 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
| 0.0 | 0.1 | GO:0032679 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
| 0.0 | 0.1 | GO:0030497 | fatty acid elongation(GO:0030497) |
| 0.0 | 0.1 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 0.0 | 0.1 | GO:0030070 | insulin processing(GO:0030070) |
| 0.0 | 0.0 | GO:0032635 | interleukin-6 production(GO:0032635) regulation of interleukin-6 production(GO:0032675) |
| 0.0 | 0.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.0 | 0.5 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.0 | 0.1 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.0 | 0.1 | GO:0072092 | ureteric bud invasion(GO:0072092) |
| 0.0 | 1.2 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.0 | 0.3 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.0 | 4.4 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.0 | 0.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.0 | 0.1 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
| 0.0 | 0.1 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
| 0.0 | 0.1 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.0 | 0.1 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
| 0.0 | 0.2 | GO:0019674 | NAD metabolic process(GO:0019674) |
| 0.0 | 0.0 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
| 0.0 | 0.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.0 | 0.1 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.0 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
| 0.0 | 0.2 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.0 | 0.2 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.0 | 2.2 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.0 | 0.0 | GO:0030279 | negative regulation of ossification(GO:0030279) |
| 0.0 | 0.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
| 0.0 | 0.1 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
| 0.0 | 0.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.0 | 0.1 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.0 | 0.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.0 | 0.1 | GO:0072679 | thymocyte migration(GO:0072679) |
| 0.0 | 0.1 | GO:0002158 | osteoclast proliferation(GO:0002158) |
| 0.0 | 0.1 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.0 | 0.0 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
| 0.0 | 0.1 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
| 0.0 | 0.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.0 | 0.5 | GO:0048259 | regulation of receptor-mediated endocytosis(GO:0048259) |
| 0.0 | 0.4 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 | 5.0 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.0 | 0.1 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.0 | 0.7 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.0 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.0 | 0.1 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
| 0.0 | 0.0 | GO:0010390 | histone monoubiquitination(GO:0010390) |
| 0.0 | 0.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.0 | 0.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.0 | 0.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.0 | 0.1 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.0 | 0.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.0 | 0.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.0 | 0.1 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.0 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.0 | 0.2 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
| 0.0 | 0.8 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
| 0.0 | 0.2 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
| 0.0 | 0.1 | GO:0098856 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.0 | 0.1 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
| 0.0 | 0.0 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.0 | 0.1 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.0 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.0 | 0.4 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.0 | 0.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.0 | 0.2 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
| 0.0 | 0.1 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.0 | 0.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
| 0.0 | 0.2 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.0 | 0.0 | GO:0043112 | receptor metabolic process(GO:0043112) |
| 0.0 | 0.2 | GO:0032438 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
| 0.0 | 0.1 | GO:0009107 | lipoate metabolic process(GO:0009106) lipoate biosynthetic process(GO:0009107) |
| 0.0 | 0.1 | GO:0017145 | stem cell division(GO:0017145) |
| 0.0 | 0.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.0 | 0.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 | 0.0 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.0 | 0.0 | GO:0099638 | endosome to plasma membrane protein transport(GO:0099638) |
| 0.0 | 0.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.0 | 0.2 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.0 | 0.2 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
| 0.0 | 0.5 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
| 0.0 | 0.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.0 | 0.3 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.0 | 0.4 | GO:0002209 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) |
| 0.0 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
| 0.0 | 0.1 | GO:0006868 | glutamine transport(GO:0006868) |
| 0.0 | 0.3 | GO:0032720 | negative regulation of tumor necrosis factor production(GO:0032720) |
| 0.0 | 0.1 | GO:0000717 | nucleotide-excision repair, DNA duplex unwinding(GO:0000717) |
| 0.0 | 0.1 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.0 | 0.1 | GO:1900116 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.0 | 1.3 | GO:0043486 | histone exchange(GO:0043486) |
| 0.0 | 0.0 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 0.0 | 0.1 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
| 0.0 | 0.1 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
| 0.0 | 0.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
| 0.0 | 0.2 | GO:1990564 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 | 0.2 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 0.0 | 0.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 | 0.1 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.0 | 1.1 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
| 0.0 | 0.1 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.0 | 0.7 | GO:1901998 | toxin transport(GO:1901998) |
| 0.0 | 1.5 | GO:0001523 | retinoid metabolic process(GO:0001523) |
| 0.0 | 0.1 | GO:0021569 | rhombomere 3 development(GO:0021569) |
| 0.0 | 0.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.0 | 0.2 | GO:0050432 | catecholamine secretion(GO:0050432) |
| 0.0 | 0.2 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.0 | 0.1 | GO:0002118 | aggressive behavior(GO:0002118) |
| 0.0 | 0.0 | GO:0061743 | motor learning(GO:0061743) |
| 0.0 | 0.2 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.0 | 0.4 | GO:0030048 | actin filament-based movement(GO:0030048) |
| 0.0 | 0.1 | GO:1901970 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.0 | 0.1 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.0 | 0.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.0 | 0.1 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
| 0.0 | 0.1 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.0 | 0.4 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 | 0.1 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.0 | 0.1 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
| 0.0 | 0.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
| 0.0 | 0.0 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
| 0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.0 | 0.3 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.0 | 0.6 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.0 | 0.1 | GO:0000023 | maltose metabolic process(GO:0000023) |
| 0.0 | 0.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.0 | 0.9 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 | 0.2 | GO:0045950 | regulation of mitotic recombination(GO:0000019) negative regulation of mitotic recombination(GO:0045950) |
| 0.0 | 0.0 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.0 | 0.1 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
| 0.0 | 0.2 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.0 | 0.7 | GO:0035418 | protein localization to synapse(GO:0035418) |
| 0.0 | 0.1 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.0 | 0.6 | GO:0006909 | phagocytosis(GO:0006909) |
| 0.0 | 0.0 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.0 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 | 0.4 | GO:0006734 | NADH metabolic process(GO:0006734) |
| 0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 | 1.3 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.0 | 0.0 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
| 0.0 | 0.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.0 | 0.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.0 | 0.1 | GO:0043379 | memory T cell differentiation(GO:0043379) regulation of memory T cell differentiation(GO:0043380) |
| 0.0 | 0.0 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
| 0.0 | 0.6 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.0 | 0.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.0 | 0.4 | GO:0001941 | postsynaptic membrane organization(GO:0001941) |
| 0.0 | 0.0 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.0 | 0.1 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.0 | 0.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 0.0 | 0.8 | GO:1902400 | signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
| 0.0 | 0.1 | GO:0001315 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.0 | 1.4 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.0 | 0.0 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 0.0 | 0.0 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
| 0.0 | 0.4 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.0 | 0.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
| 0.0 | 0.1 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
| 0.0 | 0.0 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
| 0.0 | 0.2 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.0 | 0.7 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
| 0.0 | 1.1 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
| 0.0 | 0.1 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.0 | 0.0 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
| 0.0 | 0.0 | GO:0072234 | metanephric nephron tubule development(GO:0072234) |
| 0.0 | 0.3 | GO:0006706 | steroid catabolic process(GO:0006706) |
| 0.0 | 0.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.0 | 0.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 0.0 | 0.1 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
| 0.0 | 0.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.0 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
| 0.0 | 0.0 | GO:0070227 | lymphocyte apoptotic process(GO:0070227) |
| 0.0 | 0.2 | GO:0097421 | liver regeneration(GO:0097421) |
| 0.0 | 0.2 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.0 | 0.1 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
| 0.0 | 0.1 | GO:0032536 | regulation of cell projection size(GO:0032536) |
| 0.0 | 0.0 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 0.0 | 0.1 | GO:0060591 | chondroblast differentiation(GO:0060591) |
| 0.0 | 0.0 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
| 0.0 | 0.2 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
| 0.0 | 0.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.0 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.0 | 0.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.0 | 0.1 | GO:0007135 | meiosis II(GO:0007135) meiotic sister chromatid segregation(GO:0045144) |
| 0.0 | 0.9 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.0 | 0.2 | GO:0007608 | sensory perception of smell(GO:0007608) |
| 0.0 | 0.1 | GO:0014894 | response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.0 | 0.4 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
| 0.0 | 0.1 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.0 | 0.1 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.0 | 0.0 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
| 0.0 | 0.1 | GO:0071621 | granulocyte chemotaxis(GO:0071621) |
| 0.0 | 0.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.0 | 0.0 | GO:0001909 | leukocyte mediated cytotoxicity(GO:0001909) |
| 0.0 | 0.0 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
| 0.0 | 0.0 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.0 | 0.1 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.0 | 0.7 | GO:0006939 | smooth muscle contraction(GO:0006939) |
| 0.0 | 0.0 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.0 | 0.1 | GO:0050703 | interleukin-1 alpha production(GO:0032610) interleukin-1 alpha secretion(GO:0050703) |
| 0.0 | 0.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
| 0.0 | 0.0 | GO:0097205 | glomerular filtration(GO:0003094) renal filtration(GO:0097205) |
| 0.0 | 0.0 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.0 | 0.1 | GO:0070972 | protein localization to endoplasmic reticulum(GO:0070972) |
| 0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.0 | 0.0 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.0 | 0.1 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
| 0.0 | 0.1 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
| 0.0 | 0.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.0 | 0.0 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.0 | 0.1 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 0.0 | 0.0 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.0 | 0.0 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) positive regulation by host of viral genome replication(GO:0044829) |
| 0.0 | 0.0 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.0 | 0.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.0 | 0.2 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.0 | 0.0 | GO:0003097 | renal water transport(GO:0003097) renal water absorption(GO:0070295) |
| 0.0 | 0.1 | GO:0000050 | urea cycle(GO:0000050) |
| 0.0 | 0.1 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.0 | 0.2 | GO:0034629 | cellular protein complex localization(GO:0034629) |
| 0.0 | 0.0 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
| 0.0 | 0.0 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 0.0 | 0.0 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.0 | 0.1 | GO:2001222 | regulation of neuron migration(GO:2001222) |
| 0.0 | 0.1 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
| 0.0 | 0.2 | GO:0051299 | centrosome separation(GO:0051299) |
| 0.0 | 0.1 | GO:0071711 | basement membrane organization(GO:0071711) |
| 0.0 | 0.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
| 0.0 | 0.2 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.0 | 0.1 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
| 0.0 | 0.1 | GO:0051904 | melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
| 0.0 | 0.2 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 | 0.0 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
| 0.0 | 0.1 | GO:0060674 | placenta blood vessel development(GO:0060674) |
| 0.0 | 0.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
| 0.0 | 0.1 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 | 0.0 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.0 | 0.0 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
| 0.0 | 0.0 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.0 | 0.0 | GO:0006772 | thiamine metabolic process(GO:0006772) |
| 0.0 | 0.1 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.0 | 0.2 | GO:0009755 | hormone-mediated signaling pathway(GO:0009755) |
| 0.0 | 1.8 | GO:0031424 | keratinization(GO:0031424) |
| 0.0 | 0.0 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
| 0.0 | 0.0 | GO:0046218 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.0 | 0.0 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.0 | 0.2 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
| 0.0 | 0.9 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
| 0.0 | 0.0 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.0 | 0.0 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.0 | 0.0 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
| 0.0 | 0.1 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.0 | 0.0 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
| 0.0 | 0.0 | GO:0052552 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.0 | 0.0 | GO:0036034 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.0 | 5.0 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
| 0.0 | 0.1 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
| 0.0 | 0.2 | GO:0019233 | sensory perception of pain(GO:0019233) |
| 0.0 | 0.0 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.0 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.0 | 0.0 | GO:1903725 | regulation of phospholipid metabolic process(GO:1903725) |
| 0.0 | 0.0 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.0 | 0.0 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
| 0.0 | 0.2 | GO:0098781 | ncRNA transcription(GO:0098781) |
| 0.0 | 0.0 | GO:0009642 | response to light intensity(GO:0009642) |
| 0.0 | 0.0 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
| 0.0 | 0.0 | GO:0010888 | negative regulation of lipid storage(GO:0010888) |
| 0.0 | 0.3 | GO:0048207 | vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.0 | 0.0 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.0 | 0.1 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
| 0.0 | 0.1 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.0 | 0.0 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.0 | 0.0 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.5 | 4.6 | GO:0031523 | Myb complex(GO:0031523) |
| 1.4 | 6.9 | GO:0032449 | CBM complex(GO:0032449) |
| 1.2 | 4.7 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 1.0 | 3.9 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.9 | 6.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.9 | 2.6 | GO:0032127 | dense core granule membrane(GO:0032127) |
| 0.8 | 5.4 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.7 | 0.7 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
| 0.7 | 4.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.7 | 5.9 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.6 | 0.6 | GO:0005775 | vacuolar lumen(GO:0005775) |
| 0.6 | 1.9 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.6 | 1.8 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 0.6 | 0.6 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.6 | 1.8 | GO:1990032 | parallel fiber(GO:1990032) |
| 0.6 | 10.5 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.5 | 1.6 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
| 0.5 | 4.8 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.5 | 1.6 | GO:1990015 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
| 0.5 | 1.5 | GO:0098855 | HCN channel complex(GO:0098855) |
| 0.5 | 0.5 | GO:1902710 | GABA receptor complex(GO:1902710) |
| 0.5 | 11.4 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.4 | 1.3 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 0.4 | 1.3 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
| 0.4 | 6.7 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.4 | 1.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.4 | 1.2 | GO:0000806 | Y chromosome(GO:0000806) |
| 0.4 | 1.2 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.4 | 0.4 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.4 | 2.0 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.4 | 2.0 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
| 0.4 | 2.0 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 0.4 | 5.0 | GO:0008091 | spectrin(GO:0008091) |
| 0.4 | 1.5 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 0.4 | 1.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 0.4 | 0.4 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
| 0.4 | 1.8 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.4 | 1.1 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
| 0.3 | 7.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.3 | 1.0 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 0.3 | 1.0 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 0.3 | 1.7 | GO:0044393 | microspike(GO:0044393) |
| 0.3 | 1.0 | GO:0045177 | apical part of cell(GO:0045177) |
| 0.3 | 4.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.3 | 1.6 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.3 | 1.9 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.3 | 0.6 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.3 | 2.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.3 | 1.3 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.3 | 1.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.3 | 2.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.3 | 3.5 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.3 | 0.8 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.3 | 1.9 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.3 | 2.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.3 | 0.8 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
| 0.3 | 1.3 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.3 | 6.4 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.3 | 1.6 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.3 | 1.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.3 | 0.8 | GO:0097450 | astrocyte end-foot(GO:0097450) |
| 0.3 | 1.0 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
| 0.3 | 3.1 | GO:0043219 | lateral loop(GO:0043219) |
| 0.3 | 2.1 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.3 | 0.3 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
| 0.3 | 2.3 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
| 0.2 | 2.2 | GO:0005638 | lamin filament(GO:0005638) |
| 0.2 | 1.0 | GO:0043293 | apoptosome(GO:0043293) |
| 0.2 | 1.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.2 | 4.9 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.2 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.2 | 1.4 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.2 | 2.1 | GO:0016012 | sarcoglycan complex(GO:0016012) |
| 0.2 | 8.7 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.2 | 1.6 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.2 | 1.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.2 | 2.6 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.2 | 0.2 | GO:0005607 | laminin-2 complex(GO:0005607) |
| 0.2 | 1.8 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 0.2 | 0.9 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 0.2 | 8.7 | GO:0005921 | gap junction(GO:0005921) |
| 0.2 | 0.7 | GO:0097447 | dendritic tree(GO:0097447) |
| 0.2 | 0.9 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.2 | 2.2 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.2 | 1.1 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.2 | 7.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.2 | 1.3 | GO:0000796 | condensin complex(GO:0000796) |
| 0.2 | 0.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.2 | 1.1 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 0.2 | 0.8 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.2 | 0.6 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 0.2 | 1.0 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.2 | 1.2 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.2 | 2.5 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.2 | 1.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.2 | 0.4 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.2 | 2.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.2 | 0.2 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 0.2 | 3.0 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
| 0.2 | 0.2 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
| 0.2 | 2.5 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.2 | 0.2 | GO:0043203 | axon hillock(GO:0043203) |
| 0.2 | 0.8 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.2 | 1.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.2 | 1.3 | GO:0071437 | invadopodium(GO:0071437) |
| 0.2 | 3.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.2 | 0.7 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.2 | 0.7 | GO:0031417 | NatC complex(GO:0031417) |
| 0.2 | 1.5 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
| 0.2 | 0.9 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 0.2 | 5.1 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.2 | 0.5 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.2 | 0.9 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.2 | 1.4 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.2 | 1.4 | GO:0032059 | bleb(GO:0032059) |
| 0.2 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.2 | 1.9 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.2 | 4.4 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.2 | 1.4 | GO:0031415 | NatA complex(GO:0031415) |
| 0.2 | 0.5 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
| 0.2 | 0.3 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
| 0.2 | 1.4 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.2 | 21.0 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.2 | 2.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.2 | 1.0 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.2 | 2.0 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.2 | 3.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.2 | 1.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.2 | 1.5 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.2 | 15.0 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.2 | 0.7 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 0.2 | 13.9 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.2 | 1.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.2 | 1.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.2 | 5.9 | GO:0030673 | axolemma(GO:0030673) |
| 0.2 | 9.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.2 | 4.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.2 | 0.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 0.2 | 0.5 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.2 | 0.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.2 | 0.2 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.2 | 0.5 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
| 0.2 | 0.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.2 | 0.5 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.2 | 1.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.2 | 15.1 | GO:0005901 | caveola(GO:0005901) |
| 0.2 | 0.8 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 0.2 | 0.8 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.1 | 0.1 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.1 | 1.2 | GO:0098574 | cytoplasmic side of late endosome membrane(GO:0098560) cytoplasmic side of lysosomal membrane(GO:0098574) |
| 0.1 | 0.7 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.1 | 4.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.1 | 0.4 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 0.1 | 0.4 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.1 | 0.4 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.1 | 2.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 1.0 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.1 | 3.3 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.1 | 0.5 | GO:0031045 | dense core granule(GO:0031045) |
| 0.1 | 1.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.1 | 2.0 | GO:0090543 | Flemming body(GO:0090543) |
| 0.1 | 0.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.1 | 4.2 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.1 | 0.9 | GO:0070938 | contractile ring(GO:0070938) |
| 0.1 | 0.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.1 | 0.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.1 | 1.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.1 | 0.3 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.1 | 2.3 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.1 | 3.2 | GO:0046930 | pore complex(GO:0046930) |
| 0.1 | 2.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.1 | 1.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.1 | 0.7 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
| 0.1 | 0.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 0.1 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
| 0.1 | 0.2 | GO:0045180 | basal cortex(GO:0045180) |
| 0.1 | 0.2 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.1 | 0.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.1 | 1.3 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.1 | 0.6 | GO:0044308 | axonal spine(GO:0044308) |
| 0.1 | 1.0 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.1 | 0.9 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.1 | 2.5 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.1 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.1 | 0.5 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 0.1 | 0.6 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 0.1 | 1.0 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.1 | 0.9 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.1 | 0.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.1 | 0.2 | GO:0008278 | cohesin complex(GO:0008278) |
| 0.1 | 0.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.1 | 0.8 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 0.1 | 1.8 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.1 | 9.2 | GO:0005604 | basement membrane(GO:0005604) |
| 0.1 | 2.8 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
| 0.1 | 0.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.1 | 0.4 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
| 0.1 | 0.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.1 | 0.8 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.1 | 1.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.1 | 0.2 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 0.1 | 0.4 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 0.1 | 18.7 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.1 | 0.4 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.1 | 1.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.1 | 0.2 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
| 0.1 | 0.4 | GO:0036338 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
| 0.1 | 0.3 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.1 | 1.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.1 | 0.4 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
| 0.1 | 0.7 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.1 | 0.8 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.1 | 1.0 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.1 | 3.0 | GO:0030057 | desmosome(GO:0030057) |
| 0.1 | 2.9 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.1 | 0.9 | GO:0071546 | pi-body(GO:0071546) |
| 0.1 | 6.8 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
| 0.1 | 0.3 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.1 | 0.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.1 | 1.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.1 | 1.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.1 | 0.3 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 0.1 | 1.7 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.1 | 1.7 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.1 | 1.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.1 | 0.6 | GO:0051286 | cell tip(GO:0051286) |
| 0.1 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
| 0.1 | 0.4 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
| 0.1 | 0.3 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 0.1 | 0.9 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.1 | 5.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.1 | 0.4 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.1 | 7.9 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.1 | 3.0 | GO:0002102 | podosome(GO:0002102) |
| 0.1 | 2.7 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.1 | 0.7 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.1 | 0.3 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.1 | 0.3 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.1 | 3.5 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.1 | 1.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.1 | 13.4 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.1 | 1.2 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.1 | 0.2 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
| 0.1 | 1.4 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.1 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
| 0.1 | 9.4 | GO:0001726 | ruffle(GO:0001726) |
| 0.1 | 0.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 0.1 | 0.2 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.1 | 0.8 | GO:0000801 | central element(GO:0000801) |
| 0.1 | 0.9 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.1 | 0.9 | GO:0033643 | host cell part(GO:0033643) |
| 0.1 | 0.2 | GO:1990393 | 3M complex(GO:1990393) |
| 0.1 | 0.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.1 | 2.2 | GO:0043034 | costamere(GO:0043034) |
| 0.1 | 0.4 | GO:0032021 | NELF complex(GO:0032021) |
| 0.1 | 0.9 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.1 | 0.9 | GO:0032432 | actin filament bundle(GO:0032432) |
| 0.1 | 0.4 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.1 | 6.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.1 | 1.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.1 | 0.2 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.1 | 34.5 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.1 | 1.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.1 | 0.2 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.1 | 1.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.1 | 0.4 | GO:0016589 | NURF complex(GO:0016589) |
| 0.1 | 0.1 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.1 | 2.8 | GO:0005884 | actin filament(GO:0005884) |
| 0.1 | 1.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.1 | 0.2 | GO:0008305 | integrin complex(GO:0008305) |
| 0.1 | 0.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.1 | 1.8 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.1 | 0.6 | GO:0043196 | varicosity(GO:0043196) |
| 0.1 | 0.2 | GO:0032421 | stereocilium bundle(GO:0032421) |
| 0.1 | 0.1 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
| 0.1 | 2.4 | GO:0032420 | stereocilium(GO:0032420) |
| 0.1 | 0.9 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.1 | 1.0 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.1 | 0.5 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.1 | 0.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.1 | 0.7 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.1 | 1.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.1 | 1.2 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
| 0.1 | 0.6 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.1 | 0.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
| 0.1 | 0.4 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
| 0.1 | 0.1 | GO:1990752 | microtubule end(GO:1990752) |
| 0.1 | 1.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.1 | 0.2 | GO:0033011 | perinuclear theca(GO:0033011) |
| 0.1 | 3.7 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.1 | 0.2 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.1 | 4.6 | GO:0005811 | lipid particle(GO:0005811) |
| 0.1 | 1.2 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.1 | 0.9 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 0.1 | 0.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.1 | 0.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.1 | 0.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.1 | 2.2 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.1 | 0.2 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.1 | 0.2 | GO:0031251 | PAN complex(GO:0031251) |
| 0.1 | 1.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.1 | 0.3 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.1 | 1.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.1 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 0.1 | 1.9 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.1 | 0.2 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.1 | 0.3 | GO:0005883 | neurofilament(GO:0005883) |
| 0.1 | 0.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.1 | 0.3 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.1 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.1 | 0.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.1 | 2.5 | GO:0036477 | somatodendritic compartment(GO:0036477) |
| 0.1 | 0.4 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.1 | 0.2 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 0.1 | 0.3 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.1 | 3.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.1 | 0.2 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.0 | 0.2 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
| 0.0 | 0.2 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.0 | 0.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.0 | 1.0 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.0 | 0.0 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.0 | 0.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
| 0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
| 0.0 | 0.1 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
| 0.0 | 0.2 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.0 | 0.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.0 | 1.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.0 | 2.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.0 | 0.6 | GO:0044433 | cytoplasmic vesicle part(GO:0044433) |
| 0.0 | 1.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.0 | 0.1 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
| 0.0 | 0.2 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.0 | 1.8 | GO:0005912 | adherens junction(GO:0005912) |
| 0.0 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 0.0 | 0.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.0 | 0.6 | GO:0098644 | complex of collagen trimers(GO:0098644) |
| 0.0 | 0.3 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.0 | 0.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.0 | 4.7 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.0 | 4.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.0 | 1.2 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
| 0.0 | 0.3 | GO:0010008 | endosome membrane(GO:0010008) |
| 0.0 | 0.1 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.0 | 2.8 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 0.2 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
| 0.0 | 0.0 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
| 0.0 | 1.5 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.0 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.0 | 0.1 | GO:0071159 | NF-kappaB complex(GO:0071159) |
| 0.0 | 1.4 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.0 | 0.9 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.0 | 0.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.0 | 0.1 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
| 0.0 | 3.3 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.0 | 0.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.0 | 0.4 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.0 | 0.0 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.0 | 0.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.0 | 2.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.0 | 4.4 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.0 | 0.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.0 | 1.2 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.0 | 0.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.0 | 5.6 | GO:0098857 | membrane microdomain(GO:0098857) |
| 0.0 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.0 | 0.0 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.0 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.0 | 1.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.0 | 0.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.0 | 1.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.0 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.0 | 0.2 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.0 | 4.7 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.0 | 1.4 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
| 0.0 | 0.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
| 0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.0 | 0.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.0 | 0.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.0 | 0.2 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.0 | 1.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.0 | 0.4 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
| 0.0 | 1.0 | GO:0000145 | exocyst(GO:0000145) |
| 0.0 | 0.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.0 | 3.6 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
| 0.0 | 0.0 | GO:0022626 | cytosolic ribosome(GO:0022626) |
| 0.0 | 0.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.0 | 1.4 | GO:0016235 | aggresome(GO:0016235) |
| 0.0 | 0.3 | GO:0097413 | Lewy body(GO:0097413) |
| 0.0 | 0.1 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.0 | 0.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.0 | 1.6 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.0 | 0.4 | GO:0042555 | MCM complex(GO:0042555) |
| 0.0 | 0.1 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.0 | 0.2 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.0 | 0.3 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.0 | 1.0 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.0 | 0.2 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.0 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.0 | 0.4 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.0 | 5.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.0 | 0.1 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.0 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 0.0 | 0.2 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 0.0 | 4.5 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
| 0.0 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.0 | 0.2 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.0 | 1.5 | GO:0005938 | cell cortex(GO:0005938) |
| 0.0 | 2.9 | GO:0044449 | contractile fiber part(GO:0044449) |
| 0.0 | 0.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.0 | 2.2 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
| 0.0 | 0.6 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.0 | 0.1 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.0 | 0.2 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.0 | 0.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.0 | 0.7 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.0 | 1.2 | GO:0018995 | host(GO:0018995) host cell(GO:0043657) |
| 0.0 | 0.0 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 0.0 | 2.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 0.0 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.0 | 0.4 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.0 | 0.3 | GO:0000791 | euchromatin(GO:0000791) |
| 0.0 | 0.2 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.0 | 0.5 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 0.1 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 0.0 | 0.1 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.0 | 0.1 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.0 | 1.6 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.0 | 0.5 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.0 | 0.1 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.0 | 0.8 | GO:0044309 | neuron spine(GO:0044309) |
| 0.0 | 2.9 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.0 | 0.0 | GO:1990742 | microvesicle(GO:1990742) |
| 0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
| 0.0 | 0.0 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.0 | 0.1 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.0 | 0.0 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 0.0 | 0.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.0 | 5.4 | GO:0009986 | cell surface(GO:0009986) |
| 0.0 | 0.0 | GO:0034705 | potassium channel complex(GO:0034705) |
| 0.0 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.0 | 2.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.0 | 0.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.0 | 7.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.0 | 0.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.0 | 0.0 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.0 | 0.2 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.0 | 0.0 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.0 | 0.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.0 | 0.0 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
| 0.0 | 0.1 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.0 | 0.1 | GO:0000243 | commitment complex(GO:0000243) |
| 0.0 | 0.0 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 0.0 | 1.1 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.0 | 0.1 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.0 | 0.1 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.0 | 0.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.0 | 0.1 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
| 0.0 | 0.0 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.0 | 0.0 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
| 0.0 | 10.4 | GO:0005730 | nucleolus(GO:0005730) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.5 | 10.0 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 1.4 | 4.3 | GO:0098809 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
| 1.4 | 4.2 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 1.3 | 5.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 1.2 | 6.0 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 1.2 | 9.5 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 1.2 | 3.5 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 1.1 | 6.9 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 1.1 | 3.3 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
| 1.1 | 3.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 1.0 | 4.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 1.0 | 4.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 1.0 | 3.9 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.9 | 4.5 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.9 | 2.6 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 0.8 | 2.4 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
| 0.8 | 2.4 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 0.8 | 2.4 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
| 0.8 | 3.9 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.8 | 2.3 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
| 0.8 | 3.0 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
| 0.7 | 4.4 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.7 | 3.6 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.7 | 4.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.7 | 1.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 0.7 | 2.0 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.7 | 0.7 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
| 0.7 | 3.3 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 0.6 | 2.6 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 0.6 | 5.7 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.6 | 0.6 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.6 | 2.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.6 | 8.9 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.6 | 2.9 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.6 | 2.3 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.6 | 5.8 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.6 | 2.2 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.6 | 2.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.5 | 1.6 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
| 0.5 | 4.8 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.5 | 1.6 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
| 0.5 | 2.1 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.5 | 3.1 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.5 | 3.6 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.5 | 1.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.5 | 0.5 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
| 0.5 | 2.0 | GO:0004802 | transketolase activity(GO:0004802) |
| 0.5 | 1.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 0.5 | 3.4 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.5 | 1.5 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 0.5 | 6.8 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.5 | 0.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.5 | 4.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.5 | 4.7 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 0.5 | 4.1 | GO:0043426 | MRF binding(GO:0043426) |
| 0.5 | 4.1 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.4 | 1.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.4 | 2.2 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 0.4 | 0.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.4 | 1.8 | GO:0030395 | lactose binding(GO:0030395) |
| 0.4 | 2.2 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 0.4 | 1.7 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 0.4 | 1.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.4 | 0.4 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.4 | 3.4 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.4 | 5.9 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.4 | 1.2 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 0.4 | 0.4 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.4 | 1.6 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 0.4 | 2.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.4 | 1.2 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 0.4 | 6.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.4 | 1.6 | GO:0035501 | MH1 domain binding(GO:0035501) |
| 0.4 | 0.8 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.4 | 1.5 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.4 | 4.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.4 | 0.8 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.4 | 1.1 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
| 0.4 | 1.9 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.4 | 1.9 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.4 | 1.1 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
| 0.4 | 0.4 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.4 | 1.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.4 | 7.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.4 | 1.9 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.4 | 2.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.4 | 1.1 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.4 | 1.8 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.4 | 1.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 0.4 | 3.6 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.4 | 1.1 | GO:0030984 | kininogen binding(GO:0030984) |
| 0.4 | 3.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.4 | 1.8 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
| 0.3 | 0.7 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 0.3 | 0.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.3 | 2.8 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
| 0.3 | 1.0 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.3 | 1.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.3 | 1.4 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.3 | 5.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.3 | 1.0 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 0.3 | 2.0 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.3 | 1.3 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.3 | 0.7 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.3 | 1.0 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 0.3 | 1.3 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
| 0.3 | 9.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.3 | 8.0 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.3 | 3.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.3 | 1.9 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.3 | 1.9 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.3 | 1.3 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.3 | 0.9 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
| 0.3 | 0.9 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
| 0.3 | 1.6 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.3 | 0.9 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.3 | 1.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 0.3 | 0.9 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 0.3 | 6.7 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.3 | 1.8 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 0.3 | 0.9 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 0.3 | 1.5 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
| 0.3 | 5.4 | GO:0048185 | activin binding(GO:0048185) |
| 0.3 | 0.3 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.3 | 0.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.3 | 0.3 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 0.3 | 1.8 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.3 | 3.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.3 | 0.9 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.3 | 4.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.3 | 5.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.3 | 0.9 | GO:0052856 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.3 | 1.1 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 0.3 | 2.0 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.3 | 2.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.3 | 0.9 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 0.3 | 6.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.3 | 0.8 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.3 | 0.8 | GO:0032093 | SAM domain binding(GO:0032093) |
| 0.3 | 4.6 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.3 | 0.8 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.3 | 1.6 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.3 | 11.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.3 | 1.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.3 | 1.1 | GO:0070905 | serine binding(GO:0070905) |
| 0.3 | 0.8 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 0.3 | 0.8 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.3 | 1.3 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.3 | 1.3 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.3 | 0.8 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.3 | 1.0 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
| 0.2 | 1.7 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.2 | 1.7 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.2 | 2.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.2 | 2.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.2 | 2.5 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 0.2 | 0.7 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.2 | 0.7 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.2 | 1.2 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.2 | 1.4 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.2 | 4.1 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
| 0.2 | 0.5 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
| 0.2 | 0.2 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
| 0.2 | 0.9 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.2 | 0.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.2 | 1.6 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.2 | 2.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.2 | 0.5 | GO:0004096 | catalase activity(GO:0004096) |
| 0.2 | 0.5 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.2 | 3.5 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.2 | 1.4 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.2 | 3.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.2 | 0.9 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.2 | 1.4 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 0.2 | 2.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.2 | 0.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.2 | 1.4 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.2 | 2.0 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.2 | 1.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.2 | 2.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.2 | 1.1 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 0.2 | 1.6 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
| 0.2 | 0.7 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
| 0.2 | 0.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.2 | 1.1 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
| 0.2 | 0.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.2 | 4.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.2 | 2.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.2 | 1.3 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.2 | 2.6 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.2 | 0.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.2 | 1.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.2 | 0.6 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.2 | 0.4 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 0.2 | 1.3 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.2 | 1.5 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.2 | 1.3 | GO:0052828 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 0.2 | 1.3 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.2 | 0.8 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.2 | 0.2 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
| 0.2 | 0.8 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.2 | 0.6 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 0.2 | 0.6 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
| 0.2 | 1.0 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 0.2 | 4.3 | GO:0043495 | protein anchor(GO:0043495) |
| 0.2 | 0.6 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 0.2 | 1.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.2 | 0.4 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 0.2 | 1.2 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.2 | 0.6 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.2 | 2.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.2 | 0.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.2 | 1.2 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.2 | 0.6 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.2 | 2.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.2 | 0.2 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
| 0.2 | 3.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.2 | 0.6 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
| 0.2 | 0.2 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
| 0.2 | 1.8 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.2 | 1.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.2 | 2.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.2 | 0.6 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
| 0.2 | 3.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.2 | 4.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.2 | 0.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.2 | 1.3 | GO:0071253 | connexin binding(GO:0071253) |
| 0.2 | 4.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.2 | 1.7 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
| 0.2 | 0.4 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
| 0.2 | 1.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.2 | 0.2 | GO:0043531 | ADP binding(GO:0043531) |
| 0.2 | 4.5 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.2 | 1.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.2 | 1.5 | GO:0005497 | androgen binding(GO:0005497) |
| 0.2 | 18.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.2 | 0.7 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.2 | 1.5 | GO:0008865 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.2 | 0.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.2 | 0.5 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
| 0.2 | 0.9 | GO:0031013 | troponin I binding(GO:0031013) |
| 0.2 | 0.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.2 | 3.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.2 | 0.5 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
| 0.2 | 4.7 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.2 | 0.5 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
| 0.2 | 0.4 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
| 0.2 | 0.9 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.2 | 4.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.2 | 1.8 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.2 | 0.9 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.2 | 2.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.2 | 0.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.2 | 0.4 | GO:0035173 | histone kinase activity(GO:0035173) |
| 0.2 | 0.7 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.2 | 0.5 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 0.2 | 0.7 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
| 0.2 | 9.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.2 | 0.5 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 0.2 | 0.5 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
| 0.2 | 1.1 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.2 | 0.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.2 | 2.6 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.2 | 2.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.2 | 0.9 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.2 | 0.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.2 | 0.5 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.2 | 1.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.2 | 1.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.2 | 2.5 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.2 | 0.8 | GO:0070404 | NADH binding(GO:0070404) |
| 0.2 | 1.3 | GO:0031432 | titin binding(GO:0031432) |
| 0.2 | 0.5 | GO:0008478 | pyridoxal kinase activity(GO:0008478) lithium ion binding(GO:0031403) |
| 0.2 | 1.9 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
| 0.2 | 7.1 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.2 | 3.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.2 | 2.7 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.2 | 1.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.2 | 0.3 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.2 | 1.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.2 | 0.6 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.2 | 0.5 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
| 0.2 | 2.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.2 | 3.7 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.2 | 1.5 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.2 | 1.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.2 | 21.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.2 | 0.5 | GO:0035473 | lipase binding(GO:0035473) |
| 0.2 | 0.6 | GO:0051800 | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
| 0.2 | 1.7 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
| 0.2 | 0.8 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.1 | 2.4 | GO:0005521 | lamin binding(GO:0005521) |
| 0.1 | 3.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.1 | 1.9 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.1 | 1.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.1 | 5.9 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.1 | 1.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.1 | 0.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.1 | 0.1 | GO:0001002 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
| 0.1 | 0.7 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.1 | 1.6 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.1 | 0.6 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.1 | 0.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.1 | 2.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.1 | 1.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.1 | 0.3 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
| 0.1 | 3.1 | GO:0019841 | retinol binding(GO:0019841) |
| 0.1 | 0.4 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.1 | 0.7 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.1 | 1.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.1 | 0.7 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.1 | 0.4 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.1 | 0.7 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.1 | 2.3 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.1 | 0.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.1 | 0.6 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 0.1 | 0.4 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.1 | 1.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.1 | 0.6 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.1 | 0.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.1 | 1.7 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.1 | 0.4 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
| 0.1 | 0.1 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
| 0.1 | 1.1 | GO:0015288 | porin activity(GO:0015288) |
| 0.1 | 1.2 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.1 | 1.9 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
| 0.1 | 1.4 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.1 | 2.7 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.1 | 3.1 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.1 | 0.5 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.1 | 0.8 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.1 | 0.8 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.1 | 1.3 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.1 | 3.0 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.1 | 3.0 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.1 | 0.4 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.1 | 0.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.1 | 0.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.1 | 0.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.1 | 3.3 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.1 | 0.8 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.1 | 2.5 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.1 | 1.5 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.1 | 0.4 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.1 | 1.0 | GO:0015297 | antiporter activity(GO:0015297) |
| 0.1 | 1.6 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
| 0.1 | 0.6 | GO:0008517 | folic acid transporter activity(GO:0008517) |
| 0.1 | 1.5 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.1 | 0.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.1 | 0.4 | GO:0001861 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
| 0.1 | 0.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 0.9 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.1 | 0.6 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.1 | 0.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.1 | 0.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.1 | 0.2 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.1 | 1.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.1 | 4.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.1 | 0.8 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
| 0.1 | 0.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.1 | 0.1 | GO:0000035 | acyl binding(GO:0000035) |
| 0.1 | 0.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.1 | 0.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.1 | 0.7 | GO:0031705 | bombesin receptor binding(GO:0031705) |
| 0.1 | 0.5 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.1 | 0.3 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.1 | 2.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.1 | 0.5 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.1 | 1.7 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.1 | 0.5 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.1 | 0.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.1 | 0.3 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 0.1 | 0.7 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.1 | 0.8 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.1 | 0.6 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.1 | 1.1 | GO:0097617 | annealing activity(GO:0097617) |
| 0.1 | 0.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.1 | 0.2 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
| 0.1 | 0.4 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
| 0.1 | 1.1 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.1 | 0.7 | GO:0052844 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.1 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.1 | 0.3 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 0.1 | 4.5 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.1 | 0.8 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.1 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.1 | 11.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.1 | 0.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.1 | 0.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.1 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.1 | 14.2 | GO:0005178 | integrin binding(GO:0005178) |
| 0.1 | 0.3 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
| 0.1 | 1.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.1 | 0.3 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.1 | 1.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.1 | 0.4 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.1 | 0.5 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.1 | 3.0 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.1 | 1.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
| 0.1 | 0.9 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.1 | 0.9 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.1 | 0.5 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
| 0.1 | 0.4 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 0.1 | 13.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 0.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.1 | 2.4 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.1 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.1 | 1.0 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.1 | 0.2 | GO:0035240 | dopamine binding(GO:0035240) |
| 0.1 | 0.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.1 | 2.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.1 | 4.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.1 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.1 | 0.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
| 0.1 | 0.2 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.1 | 0.4 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
| 0.1 | 0.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.1 | 0.6 | GO:0042835 | BRE binding(GO:0042835) |
| 0.1 | 0.2 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.1 | 0.6 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 0.1 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.1 | 1.4 | GO:0089720 | caspase binding(GO:0089720) |
| 0.1 | 1.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.1 | 1.1 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.1 | 0.6 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
| 0.1 | 0.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.1 | 0.7 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
| 0.1 | 0.1 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 0.1 | 1.6 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
| 0.1 | 1.6 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.1 | 0.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.1 | 0.4 | GO:0016248 | channel inhibitor activity(GO:0016248) |
| 0.1 | 0.6 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 0.1 | 0.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 0.1 | 0.1 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.1 | 3.6 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.1 | 0.9 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.1 | 0.8 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.1 | 0.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.1 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.1 | 3.1 | GO:0008066 | glutamate receptor activity(GO:0008066) |
| 0.1 | 0.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.1 | 1.5 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.1 | 0.3 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
| 0.1 | 1.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.1 | 3.9 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.1 | 0.6 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.1 | 1.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
| 0.1 | 0.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.1 | 2.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.1 | 0.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.1 | 0.3 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 0.1 | 0.4 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.1 | 0.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.1 | 0.4 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.1 | 0.3 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
| 0.1 | 5.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.1 | 0.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
| 0.1 | 1.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.1 | 0.4 | GO:0004532 | exoribonuclease activity(GO:0004532) |
| 0.1 | 0.2 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
| 0.1 | 0.5 | GO:0046790 | virion binding(GO:0046790) |
| 0.1 | 0.3 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
| 0.1 | 2.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.1 | 0.5 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.1 | 2.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.1 | 2.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.1 | 0.6 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.1 | 0.4 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
| 0.1 | 15.3 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.1 | 2.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.1 | 0.3 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
| 0.1 | 0.3 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.1 | 0.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.1 | 1.0 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.1 | 2.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.1 | 0.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.1 | 0.3 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.1 | 0.5 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 0.1 | 0.3 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 0.1 | 4.2 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.1 | 1.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.1 | 0.2 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.1 | 0.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.1 | 0.4 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.1 | 0.6 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.1 | 1.0 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.1 | 0.3 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
| 0.1 | 0.1 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.1 | 0.3 | GO:0005536 | glucose binding(GO:0005536) |
| 0.1 | 0.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.1 | 1.0 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.1 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.1 | 0.3 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 0.1 | 0.8 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.1 | 2.1 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.1 | 0.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.1 | 0.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.1 | 0.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.1 | 0.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.1 | 0.6 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.1 | 1.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.1 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 0.1 | 0.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
| 0.1 | 0.5 | GO:0004386 | helicase activity(GO:0004386) |
| 0.1 | 0.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
| 0.1 | 0.2 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
| 0.1 | 1.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.1 | 3.0 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.1 | 0.1 | GO:0047115 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
| 0.1 | 0.3 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.1 | 0.3 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.1 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.1 | 1.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.1 | 0.3 | GO:1903135 | cupric ion binding(GO:1903135) |
| 0.1 | 0.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.1 | 0.6 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.1 | 9.5 | GO:0002020 | protease binding(GO:0002020) |
| 0.1 | 18.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.1 | 1.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.1 | 0.1 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.1 | 0.1 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
| 0.1 | 0.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.1 | 0.2 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
| 0.1 | 0.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.1 | 0.3 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.1 | 24.4 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.1 | 0.6 | GO:0036122 | BMP binding(GO:0036122) |
| 0.1 | 0.2 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 0.1 | 0.2 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
| 0.1 | 0.3 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.1 | 0.4 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 0.1 | 0.2 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
| 0.1 | 2.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.1 | 1.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 0.1 | 0.8 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.1 | 0.3 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.1 | 1.6 | GO:0043236 | laminin binding(GO:0043236) |
| 0.1 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.1 | 0.4 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
| 0.1 | 0.2 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.1 | 0.8 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.1 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.1 | 0.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.1 | 0.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.1 | 0.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.1 | 0.2 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
| 0.1 | 0.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
| 0.1 | 1.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.1 | 0.3 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.1 | 0.2 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
| 0.1 | 1.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.1 | 0.9 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.1 | 0.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.1 | 2.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.1 | 0.3 | GO:0004629 | phospholipase C activity(GO:0004629) |
| 0.1 | 0.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.1 | 0.2 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 0.1 | 0.3 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.1 | 0.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.1 | 0.9 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.1 | 0.1 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.1 | 0.2 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
| 0.1 | 1.8 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.1 | 1.6 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.1 | 4.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.1 | 0.8 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
| 0.1 | 0.3 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 0.1 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.1 | 0.6 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.1 | 0.5 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 0.1 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.1 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.1 | 0.5 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 0.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.1 | 0.3 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
| 0.1 | 1.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.1 | 1.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.1 | 0.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.1 | 0.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.1 | 2.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.1 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
| 0.1 | 0.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.1 | 0.4 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.1 | 0.2 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 0.1 | 0.3 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
| 0.1 | 0.3 | GO:0070728 | leucine binding(GO:0070728) |
| 0.1 | 0.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.1 | 0.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 0.1 | 0.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.1 | 2.4 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
| 0.1 | 0.9 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
| 0.1 | 3.0 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.1 | 0.5 | GO:0031386 | protein tag(GO:0031386) |
| 0.1 | 0.2 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
| 0.1 | 0.4 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.1 | 0.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.0 | 0.3 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.0 | 0.3 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
| 0.0 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.0 | 0.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.0 | 0.3 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.0 | 0.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.0 | 1.9 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.0 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.0 | 0.2 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.0 | 0.0 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.0 | 0.3 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.0 | 0.3 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.0 | 1.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.0 | 0.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.0 | 0.6 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
| 0.0 | 0.5 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.0 | 0.2 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 0.0 | 0.1 | GO:0016671 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
| 0.0 | 4.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.0 | 0.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.0 | 0.1 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.0 | 0.2 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.0 | 0.3 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
| 0.0 | 1.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.0 | 1.1 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.0 | 0.0 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.0 | 0.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.0 | 0.3 | GO:0070061 | fructose transmembrane transporter activity(GO:0005353) fructose binding(GO:0070061) |
| 0.0 | 0.2 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
| 0.0 | 0.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.0 | 0.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.0 | 0.2 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.0 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
| 0.0 | 0.1 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.0 | 0.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.0 | 0.0 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 0.0 | 4.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.0 | 0.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.0 | 0.5 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
| 0.0 | 0.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
| 0.0 | 1.6 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.0 | 0.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.0 | 5.6 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
| 0.0 | 2.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.0 | 0.0 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
| 0.0 | 0.2 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
| 0.0 | 0.4 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 0.0 | 2.0 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 0.0 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.0 | 0.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.0 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.0 | 13.7 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.0 | 0.1 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
| 0.0 | 0.1 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.0 | 0.2 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
| 0.0 | 0.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
| 0.0 | 0.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.0 | 0.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.0 | 0.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.0 | 0.8 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
| 0.0 | 3.1 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.0 | 0.3 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.0 | 0.1 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 0.0 | 0.4 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
| 0.0 | 0.4 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.0 | 0.2 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.0 | 0.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.0 | 0.1 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
| 0.0 | 0.1 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
| 0.0 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.0 | 0.0 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
| 0.0 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.0 | 1.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 0.1 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 0.0 | 0.4 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.0 | 0.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.0 | 0.2 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.0 | 0.0 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 0.0 | 0.2 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.0 | 0.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.0 | 3.2 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.0 | 0.1 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
| 0.0 | 0.5 | GO:0005549 | odorant binding(GO:0005549) |
| 0.0 | 0.1 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.0 | 0.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.0 | 1.5 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 0.1 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
| 0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.0 | 1.0 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.0 | 0.2 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.0 | 0.1 | GO:0070283 | lipoate synthase activity(GO:0016992) radical SAM enzyme activity(GO:0070283) |
| 0.0 | 0.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
| 0.0 | 0.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.0 | 0.2 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.0 | 0.1 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 0.0 | 0.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 0.0 | 0.1 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
| 0.0 | 0.2 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 0.0 | 0.2 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.0 | 0.9 | GO:0004857 | enzyme inhibitor activity(GO:0004857) |
| 0.0 | 1.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.0 | 0.5 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
| 0.0 | 0.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.0 | 0.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.0 | 0.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.0 | 0.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
| 0.0 | 0.2 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
| 0.0 | 0.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.0 | 0.5 | GO:0045182 | translation regulator activity(GO:0045182) |
| 0.0 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.0 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
| 0.0 | 0.0 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 0.0 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
| 0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
| 0.0 | 0.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.0 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.0 | 1.8 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.0 | 0.1 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 0.0 | 1.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.0 | 0.1 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.0 | 0.2 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
| 0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.0 | 0.0 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
| 0.0 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.0 | 0.8 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.0 | 0.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.0 | 0.0 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.0 | 0.1 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
| 0.0 | 0.1 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.0 | 0.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.0 | 0.0 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
| 0.0 | 0.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.0 | 0.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.0 | 0.0 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.0 | 0.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.0 | 0.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
| 0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.0 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.0 | 0.2 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.0 | 0.1 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 0.0 | 0.2 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.0 | 0.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.0 | 0.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.0 | 0.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.0 | 0.1 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.0 | 0.1 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 0.0 | 0.1 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.0 | 0.3 | GO:0031005 | filamin binding(GO:0031005) |
| 0.0 | 0.0 | GO:0004527 | exonuclease activity(GO:0004527) |
| 0.0 | 0.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.0 | 0.1 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
| 0.0 | 0.4 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.0 | 0.0 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 0.0 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.0 | 0.1 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
| 0.0 | 0.1 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.0 | 1.9 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
| 0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
| 0.0 | 0.2 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.0 | 0.1 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
| 0.0 | 0.1 | GO:0016841 | carbon-nitrogen lyase activity(GO:0016840) ammonia-lyase activity(GO:0016841) |
| 0.0 | 0.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.0 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.0 | 0.6 | GO:0030695 | GTPase regulator activity(GO:0030695) |
| 0.0 | 0.8 | GO:0005518 | collagen binding(GO:0005518) |
| 0.0 | 0.0 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.0 | 0.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.0 | 0.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
| 0.0 | 0.0 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.0 | 0.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.0 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.0 | 0.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.0 | 0.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.0 | 0.0 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 0.0 | 0.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.0 | 0.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.0 | 0.0 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.0 | 0.9 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
| 0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.0 | 0.2 | GO:0008061 | chitin binding(GO:0008061) |
| 0.0 | 0.1 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.0 | 0.1 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
| 0.0 | 0.0 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.0 | 0.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.0 | 0.0 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.0 | 0.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.0 | 0.3 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
| 0.0 | 0.1 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.0 | 0.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.0 | 0.2 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.0 | 0.0 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.0 | 0.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.0 | 0.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.0 | 0.1 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.0 | 0.1 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
| 0.0 | 0.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.0 | 0.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.0 | 0.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.0 | 0.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.9 | 1.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.8 | 2.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.7 | 12.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.5 | 10.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.3 | 15.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.3 | 9.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.3 | 5.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.3 | 15.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.3 | 4.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.2 | 12.1 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.2 | 7.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.2 | 3.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.2 | 0.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.2 | 14.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.2 | 12.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.2 | 8.6 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.2 | 2.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.2 | 1.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.2 | 1.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.2 | 4.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.2 | 5.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.2 | 2.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.2 | 2.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.2 | 3.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.2 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.2 | 5.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 4.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.1 | 8.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.1 | 9.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.1 | 10.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.1 | 1.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.1 | 6.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.1 | 1.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.1 | 1.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 2.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.1 | 3.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.1 | 5.4 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.1 | 7.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.1 | 2.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.1 | 37.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 1.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.1 | 2.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.1 | 1.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.1 | 1.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.1 | 3.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.1 | 1.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.1 | 3.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 7.1 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.1 | 1.5 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.1 | 6.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.1 | 0.9 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.1 | 7.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.1 | 1.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.1 | 2.7 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.1 | 0.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.1 | 9.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.1 | 2.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.1 | 3.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.1 | 2.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.1 | 1.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.1 | 3.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.1 | 5.5 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.1 | 2.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.1 | 1.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.1 | 0.4 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.1 | 0.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.1 | 0.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.1 | 0.2 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.1 | 0.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.1 | 2.7 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.1 | 4.2 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.1 | 1.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.1 | 2.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.1 | 2.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.1 | 0.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.1 | 3.6 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.1 | 1.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.1 | 14.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.1 | 1.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.1 | 1.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.1 | 2.7 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.1 | 1.2 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.1 | 0.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.0 | 0.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.0 | 0.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.0 | 0.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.0 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.0 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.0 | 0.5 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.0 | 0.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.0 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.0 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.0 | 0.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.0 | 0.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.0 | 1.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.0 | 1.0 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.0 | 0.5 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.0 | 0.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.0 | 1.3 | PID ATR PATHWAY | ATR signaling pathway |
| 0.0 | 0.4 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.0 | 0.9 | PID P73PATHWAY | p73 transcription factor network |
| 0.0 | 0.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.0 | 7.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.0 | 0.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.0 | 0.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.0 | 0.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.0 | 0.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.0 | 0.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.0 | 1.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.0 | 0.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.0 | 0.4 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.0 | 0.1 | PID FOXO PATHWAY | FoxO family signaling |
| 0.0 | 0.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.7 | 11.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.6 | 6.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.6 | 12.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.5 | 1.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 0.4 | 11.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.4 | 4.9 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.4 | 7.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.4 | 9.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.3 | 15.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.3 | 5.1 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.3 | 8.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.3 | 6.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.3 | 5.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.3 | 18.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.3 | 6.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.3 | 4.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.2 | 3.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.2 | 0.7 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
| 0.2 | 7.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.2 | 1.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.2 | 3.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.2 | 13.3 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
| 0.2 | 5.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.2 | 9.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.2 | 4.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.2 | 6.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.2 | 2.9 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.2 | 6.7 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.2 | 3.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.2 | 1.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.2 | 3.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.2 | 0.6 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 0.2 | 2.6 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.2 | 2.8 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.2 | 0.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.2 | 4.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.2 | 0.4 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 0.2 | 3.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.2 | 3.2 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.2 | 5.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.2 | 3.5 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.2 | 12.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.2 | 3.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.2 | 1.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.2 | 8.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.2 | 2.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.2 | 5.9 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.2 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.2 | 3.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.2 | 9.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.2 | 0.2 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
| 0.2 | 1.4 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.1 | 1.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.1 | 0.7 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.1 | 2.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.1 | 0.6 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 0.1 | 3.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.1 | 2.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.1 | 2.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.1 | 7.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.1 | 2.5 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
| 0.1 | 4.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.1 | 3.0 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.1 | 1.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.1 | 2.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.1 | 11.7 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.1 | 3.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.1 | 2.4 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.1 | 4.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.1 | 1.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.1 | 2.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.1 | 1.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.1 | 1.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.1 | 0.9 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.1 | 1.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.1 | 3.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.1 | 0.4 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
| 0.1 | 6.6 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
| 0.1 | 0.9 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
| 0.1 | 2.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.1 | 1.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.1 | 0.8 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.1 | 6.0 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.1 | 4.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.1 | 2.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 2.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.1 | 7.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.1 | 2.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.1 | 3.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.1 | 0.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
| 0.1 | 1.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.1 | 1.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.1 | 2.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.1 | 4.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.1 | 18.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 3.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.1 | 0.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.1 | 3.0 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.1 | 3.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.1 | 0.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.1 | 0.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.1 | 0.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.1 | 0.8 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
| 0.1 | 1.4 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.1 | 1.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.1 | 1.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.1 | 0.6 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.1 | 0.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.1 | 2.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.1 | 0.1 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
| 0.1 | 1.5 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.1 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.1 | 0.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.1 | 1.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.1 | 1.7 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
| 0.1 | 0.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.1 | 2.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.1 | 1.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.1 | 5.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.1 | 0.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.1 | 1.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.1 | 0.3 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
| 0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.1 | 0.8 | REACTOME OPSINS | Genes involved in Opsins |
| 0.1 | 0.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.1 | 0.2 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
| 0.1 | 0.8 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.1 | 1.1 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
| 0.1 | 1.3 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.1 | 0.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.1 | 1.5 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 0.1 | 0.3 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.1 | 0.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.1 | 0.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.1 | 1.1 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.1 | 0.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.1 | 1.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 0.6 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
| 0.1 | 1.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.1 | 2.9 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.1 | 1.1 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.0 | 0.6 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.0 | 2.3 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
| 0.0 | 0.4 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
| 0.0 | 1.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.0 | 0.5 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 0.0 | 0.3 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
| 0.0 | 7.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.0 | 1.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.0 | 1.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.0 | 0.3 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
| 0.0 | 7.5 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
| 0.0 | 1.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.0 | 1.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.0 | 0.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.0 | 0.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.0 | 0.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.0 | 0.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.0 | 3.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.0 | 2.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.0 | 0.4 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 0.0 | 2.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.0 | 0.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.0 | 0.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.0 | 1.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.0 | 0.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.0 | 2.0 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.0 | 0.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.0 | 0.8 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.0 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.0 | 0.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.0 | 0.6 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
| 0.0 | 1.4 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 0.0 | 0.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.0 | 0.6 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.0 | 0.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.0 | 0.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.0 | 0.5 | REACTOME TRANSLATION | Genes involved in Translation |
| 0.0 | 0.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.0 | 0.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.0 | 1.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.0 | 0.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 0.0 | 0.0 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.0 | 0.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.0 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.0 | 0.4 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.0 | 0.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.0 | 0.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.0 | 0.3 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.0 | 1.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.0 | 0.2 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.0 | 0.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.0 | 0.7 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
| 0.0 | 0.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.0 | 0.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.0 | 0.0 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
| 0.0 | 0.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
| 0.0 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.0 | 0.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.0 | 0.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |